US10008681B2 - Platinum(II) complexes for OLED applications - Google Patents

Platinum(II) complexes for OLED applications Download PDF

Info

Publication number
US10008681B2
US10008681B2 US15/054,247 US201615054247A US10008681B2 US 10008681 B2 US10008681 B2 US 10008681B2 US 201615054247 A US201615054247 A US 201615054247A US 10008681 B2 US10008681 B2 US 10008681B2
Authority
US
United States
Prior art keywords
mixture
mmol
precursor
ethyl acetate
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active, expires
Application number
US15/054,247
Other versions
US20160181551A1 (en
Inventor
Chi Ming Che
Chi Fai Kui
Chi Chung Kwok
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Versitech Ltd
Original Assignee
Versitech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Versitech Ltd filed Critical Versitech Ltd
Priority to US15/054,247 priority Critical patent/US10008681B2/en
Assigned to THE UNIVERSITY OF HONG KONG reassignment THE UNIVERSITY OF HONG KONG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHE, CHI MING, KUI, CHI FAI, KWOK, CHI CHUNG
Assigned to VERSITECH LIMITED reassignment VERSITECH LIMITED ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: THE UNIVERSITY OF HONG KONG
Publication of US20160181551A1 publication Critical patent/US20160181551A1/en
Priority to US15/950,650 priority patent/US10243154B2/en
Application granted granted Critical
Publication of US10008681B2 publication Critical patent/US10008681B2/en
Active legal-status Critical Current
Adjusted expiration legal-status Critical

Links

Images

Classifications

    • H01L51/0087—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
    • C07F15/0086—Platinum compounds
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00—Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06—Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B33/00—Electroluminescent light sources
    • H05B33/12—Light sources with substantially two-dimensional radiating surfaces
    • H05B33/14—Light sources with substantially two-dimensional radiating surfaces characterised by the chemical or physical composition or the arrangement of the electroluminescent material, or by the simultaneous addition of the electroluminescent material in or onto the light source
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00—Organic light-emitting devices
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00—Organic light-emitting devices
    • H10K50/80—Constructional details
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/30—Coordination compounds
    • H10K85/341—Transition metal complexes, e.g. Ru(II)polypyridine complexes
    • H10K85/346—Transition metal complexes, e.g. Ru(II)polypyridine complexes comprising platinum
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1003—Carbocyclic compounds
    • C09K2211/1007—Non-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1003—Carbocyclic compounds
    • C09K2211/1011—Condensed systems
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1003—Carbocyclic compounds
    • C09K2211/1014—Carbocyclic compounds bridged by heteroatoms, e.g. N, P, Si or B
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10—Non-macromolecular compounds
    • C09K2211/1018—Heterocyclic compounds
    • C09K2211/1025—Heterocyclic compounds characterised by ligands
    • C09K2211/1029—Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00—Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/18—Metal complexes
    • C09K2211/185—Metal complexes of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd
    • H01L51/0072—
    • H01L51/0094—
    • H01L51/5016—
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2101/00—Properties of the organic materials covered by group H10K85/00
    • H10K2101/10—Triplet emission
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00—Organic light-emitting devices
    • H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11—OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/40—Organosilicon compounds, e.g. TIPS pentacene
    • H—ELECTRICITY
    • H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60—Organic compounds having low molecular weight
    • H10K85/649—Aromatic compounds comprising a hetero atom
    • H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572—Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole

Definitions

  • the present invention relates to a class platinum(II) complexes, their preparation methods, and their applications in organic light-emitting diodes (OLED).
  • OLEDs organic light-emitting diodes
  • OLED related technologies are rapidly developing.
  • Organic-based emitting material is one of the most important core technologies in OLED; therefore, much effort has been devoted to this area. Since triplet emitters could fully utilize all excitons generated in the device, they are the focus in the field of emissive material development.
  • P-OLED phosphorescent platinum(II) complex
  • Pt(OEP) phosphorescent platinum(II) complex
  • OEP octaethylporphin
  • osmium(II) complex [Os(CN) 2 (PPh 3 )(X)]
  • X 4,4′-diphenyl-2,2′-bipyridine)
  • High efficiency P-OLEDs have continuously been fabricated from new phosphorescent materials and are useful in various mobile electronics devices such as cellphones.
  • This present invention relates to novel platinum(II)-based materials having the chemical structure of Structure I. Also provided are methods of preparing the platinum(II)-based materials, and their applications in organic light-emitting diode (OLED).
  • OLED organic light-emitting diode
  • platinum(II)-based compounds of Structure I are shown as follows:
  • R 1 -R 15 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group;
  • each pair of adjacent R groups of R 1 -R 15 can be independently two separated groups (or atoms) or one group (or atom), and fonn 5-8 member ring(s) with 2 to 4 X groups;
  • X 1 -X 20 are independently boron, carbon, nitrogen, oxygen, silicon, germanium, phosphorous, sulphur or selenium.
  • the platinum(II) center is surrounded by the ligands featuring with a 6-5-6 fused membered ring system (the bolded line in structure I).
  • R 11 is aryl or substituted aryl group
  • R 10 can be one of the carbon atoms on R 11 , thereby forming a 6-5-6 fused ring system with the adjacent aryl ring.
  • the present invention also provides devices fabricated from the platinum(II)-based compounds of Structure I.
  • the devices of the invention exhibit high efficiency and low roll-off.
  • FIG. 1 shows one embodiment of the synthetic scheme of the platinum(II)-based organometallic compounds of Structure I.
  • the compound of Structure I is prepared using a ligand of Structure II.
  • FIG. 2 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 1.
  • FIG. 3 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 2.
  • FIG. 4 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 3.
  • FIG. 5 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 4.
  • FIG. 6 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 5.
  • FIG. 7 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 6.
  • Amino refers to a primary, secondary, or tertiary amine which may be optionally substituted. Specifically included are secondary or tertiary amine nitrogen atoms which are members of a heterocyclic ring. Also specifically included, for example, are secondary or tertiary amino groups substituted by an acyl moiety. Some non-limiting examples of an amino group include —NR′R′′ wherein each of R′ and R′′ is independently H, alkyl, aryl, aralkyl, alkaryl, cycloalkyl, acyl, heteroalkyl, heteroaryl or heterocycyl.
  • Alkyl refers to a fully saturated acyclic monovalent radical containing carbon and hydrogen, and which may be branched or a straight chain.
  • alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, n-heptyl, n-hexyl, n-octyl, and n-decyl.
  • Alkylamino means a radical —NHR or —NR 2 where each R is independently an alkyl group.
  • Representative examples of alkylamino groups include, but are not limited to, methylamino, (1-methylethyl)amino, methylamino, dimethyl amino, methylethylamino, and di(1-methyethyl)amino.
  • hydroxyalkyl means an alkyl radical as defined herein, substituted with one or more, preferably one, two or three hydroxy groups.
  • Representative examples of hydroxyalkyl include, but are not limited to, hydroxymethyl, 2-hydroxyethyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-(hydroxymethyl)-2-methylpropyl, 2-hydroxybutyl, 3-hydroxybutyl, 4-hydroxybutyl, 2,3-dihydroxypropyl, 2-hydroxy-1-hydroxymethylethyl, 2,3-dihydroxybutyl, 3,4-dihydroxybutyl and 2-(hydroxymethyl)-3-hydroxy-propyl, preferably 2-hydroxyethyl, 2,3-dihydroxypropyl, and 1-(hydroxymethyl)2-hydroxyethyl.
  • alkoxy refers the radical —OR x .
  • exemplary alkoxy groups include, but are not limited to, methoxy, ethoxy, and propoxy.
  • Aromatic or “aromatic group” refers to aryl or heteroaryl.
  • Aryl refers to optionally substituted carbocyclic aromatic groups.
  • the aryl group includes phenyl, biphenyl, naphthyl, substituted phenyl, substituted biphenyl or substituted naphthyl. In other embodiments, the aryl group is phenyl or substituted phenyl.
  • Alkyl refers to an alkyl group which is substituted with an aryl group. Some non-limiting examples of aralkyl include benzyl and phenethyl.
  • “Acyl” refers to a monovalent group of the formula —C( ⁇ O)H, —C( ⁇ O)-alkyl, —C( ⁇ O)-aryl, —C( ⁇ O)-aralkyl, or —C( ⁇ O)-alkaryl.
  • Halogen refers to fluorine, chlorine, bromine and iodine.
  • “Styryl” refers to a univalent radical C 6 H 5 —CH ⁇ CH— derived from styrene.
  • “Substituted” as used herein to describe a compound or chemical moiety refers to that at least one hydrogen atom of that compound or chemical moiety is replaced with a second chemical moiety.
  • substituents are those found in the exemplary compounds and embodiments disclosed herein, as well as halogen; alkyl; heteroalkyl; alkenyl; alkynyl; aryl; heteroaryl; hydroxy; alkoxyl; amino; nitro; thiol; thioether; imine; cyano; amido; phosphonato; phosphine; carboxyl; thiocarbonyl; sulfonyl; sulfonamide; ketone; aldehyde; ester; oxo; haloalkyl (e.g., trifluoromethyl); carbocyclic cycloalkyl, which can be monocyclic or fused or non-fused polycyclic (e.g., cyclopropyl, cycloprop
  • substituents can optionally be further substituted with a substituent selected from such groups. All chemical groups disclosed herein can be substituted, unless it is specified otherwise.
  • “substituted” alkyl, alkenyl, alkynyl, aryl, hydrocarbyl or heterocyclo moieties described herein are moieties which are substituted with a hydrocarbyl moiety, a substituted hydrocarbyl moiety, a heteroatom, or a heterocyclo.
  • substituents may include moieties in which a carbon atom is substituted with a heteroatom such as nitrogen, oxygen, silicon, phosphorus, boron, sulfur, or a halogen atom.
  • substituents may include halogen, heterocyclo, alkoxy, alkenoxy, alkynoxy, aryloxy, hydroxy, protected hydroxy, keto, acyl, acyloxy, nitro, amino, amido, cyano, thiol, ketals, acetals, esters and ethers.
  • the present invention provides platinum(II)-based organometallic compounds.
  • an organometallic complex represented by Structure I also referred herein as cyclometallated complexes.
  • the platinum center in Structure I is in +2 oxidation state and has a square planar geometry.
  • the coordination sites of the platinum center are occupied by a tetradentate ligand.
  • the tetradentate ligand featuring with 6-5-6 fused membered rings coordinates to the platinum center through a metal-oxygen bond, a nitrogen donor bond, a metal-carbon bond and a nitrogen donor bond in a sequence of O, N, C, N (O ⁇ N ⁇ C*N ligand; i.e., 4 connecting covalent bonds (either single or double) between O ⁇ N, 3 connecting covalent bonds (either single or double) between N ⁇ C, 4 connecting covalent bonds (either single or double) between C*N).
  • the metal-oxygen bond is a bond between deprotonated phenol or substituted phenol and platinum, the nitrogen donors are from pyridine and/or isoquinoline groups, and the metal-carbon bond is formed by benzene or substituted benzene and platinum.
  • the platinum(II)-based organometallic compounds have the chemical structure of Structure I
  • R 1 -R 15 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group;
  • each pair of adjacent R groups of R 1 -R 15 can be independently two separated groups (or atoms) or one group (or atom), and form 5-8 member ring(s) with 2 to 4 X groups;
  • X 1 -X 20 are independently boron, carbon, nitrogen, oxygen, silicon, germanium, phosphorous, sulphur or selenium.
  • the platinum(II) center is surrounded by the ligands featuring with a 6-5-6 fused membered ring system (the bolded line in structure I).
  • R 11 is aryl or substituted aryl group
  • R 10 can be one of the carbon atoms on R 11 thereby forming a 6-5-6 fused ring system with the adjacent aryl ring.
  • each R 1 -R 15 is independently hydrogen, halogen (such as fluorine, chlorine bromine, and iodine), hydroxyl, an unsubstituted alkyl containing from 1 to 10 carbon atoms, a substituted alkyl containing from 1 to 20 carbon atoms, cycloalkyl containing from 4 to 20 carbon atoms, an unsubstituted aryl containing from 6 to 20 carbon atoms, a substituted aryl containing from 6 to 20 carbon atoms, acyl containing from 1 to 20 carbon atoms, alkoxy containing from 1 to 20 carbon atoms, acyloxy containing from 1 to 20 carbon atoms, amino, nitro, acylamino containing from 1 to 20 carbon atoms, aralkyl containing from 1 to 20 carbon atoms, cyano, carboxyl containing from 1 to 20 carbon atoms, thiol, styryl, aminocarbonyl containing from 1 to 20 carbon
  • the total number of carbon atoms provided by the R 1 -R 15 groups is from 1 to 40.
  • the total number of carbon atoms provided by the R 1 -R 15 groups is from 2 to 30.
  • organometallic complexes with Structure I are shown as follows:
  • the organometallic complex with the chemical structure of Structure I can be prepared from a tetradentate ligand with a chemical structure of Structure II:
  • R 1 -R 15 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group;
  • each pair of adjacent R groups of R 1 -R 15 can be independently two separated groups (or atoms) or one group (or atom), and form 5-8 member ring(s) with 2 to 4 X groups;
  • X 1 -X 20 are independently boron, carbon, nitrogen, oxygen, silicon, germanium, phosphorous, sulphur or selenium.
  • R 11 is aryl or substituted aryl group
  • R 10 can be one of the carbon atoms on R 11 thereby forming a 6-5-6 fused ring system with the adjacent aryl ring.
  • each R 1 -R 15 is independently hydrogen, halogen (such as fluorine, chlorine bromine, and iodine), hydroxyl, an unsubstituted alkyl containing from 1 to 10 carbon atoms, a substituted alkyl containing from 1 to 20 carbon atoms, cycloalkyl containing from 4 to 20 carbon atoms, an unsubstituted aryl containing from 6 to 20 carbon atoms, a substituted aryl containing from 6 to 20 carbon atoms, acyl containing from 1 to 20 carbon atoms, alkoxy containing from 1 to 20 carbon atoms, acyloxy containing from 1 to 20 carbon atoms, amino, nitro, acylamino containing from 1 to 20 carbon atoms, aralkyl containing from 1 to 20 carbon atoms, cyano, carboxyl containing from 1 to 20 carbon atoms, thio, styryl, aminocarbonyl containing from 1 to 20 carbon carbon atoms
  • the total number of carbon atoms provided by the R 1 -R 15 groups is from 1 to 40.
  • the total number of carbon atoms provided by the R 1 -R 15 groups is from 2 to 30.
  • the tetradentate ligands with Structure II can be prepared by a series of reactions depicted in FIG. 1 .
  • Precursor 210 reacts with Precursor 220 or Precursor 230 reacts with Precursor 240, through Reaction 301 to form Precursor 260 or through Reaction 302 to form Precursor 280, depending on the chemical structure of the Precursor 210-Precursor 240. If Precursor 260 is produced, it is transformed to Precursor 270 through Reaction 305 and then transformed to Precursor 280 through Reaction 306. Finally, Precursor 208 is transformed to a ligand with a chemical structure of Structure II by Reaction 307. Precursor 260 and Precursor 280 can also be produced by reacting Precursor 240 with Precursor 250 through Reaction 303 or Reaction 304. All reactions 301-307 can be a single step or multi-step reaction.
  • Reaction 301 comprises reacting Precursor 210 and Precursor 220 or Precursor 230 and Precursor 240. In one embodiment, Reaction 301 is performed in the presence of excess ammonium acetate and a solvent under a reflux condition. Suitable solvents for Reaction 301 include, but are not limited to, methanol.
  • Reaction 305 comprises a palladium coupling reaction using bis[2-(diphenylphoshpine)phenyl]ether (DPE-phos) as a ligand, tris(dibenzylideneacetone)dipalladium(0) as the catalyst, potassium tert-butoxide as the base and toluene as the solvent, under an inert nitrogen environment at 80° C.
  • DPE-phos bis[2-(diphenylphoshpine)phenyl]ether
  • Reaction 306 is the same as Reaction 305.
  • Reaction 307 comprises reacting pyridine hydrogen chloride with Precursor 280.
  • Reaction 307 comprises reacting carbon tetarbromide with Precursor 280.
  • the present invention provides a method of preparing the organometallic complex with chemical structure of Structure I, comprising reacting a ligand with chemical structure of Structure II with a platinum(II) salt in the presence of solvent(s).
  • a platinum(II) salt is potassium tetrachloroplatinate.
  • the solvents are glacial acetic acid and chloroform.
  • the platinum(II) based organometallic complexes having the chemical structure of Structure I show strong emission with high solution quantum yield.
  • the OLED fabricated using the organometallic complex of Structure I shows a high efficiency of greater than 70 cd/A. In another embodiment, the OLED fabricated using the organometallic complex of Structure I shows a high efficiency of greater than 40 cd/A, including, but not limited to, greater than 45 cd/A, 50 cd/A, 55 cd/A, 60 cd/A, 65 cd/A, 70 cd/A, 75 cd/A, 80 cd/A, or 85 cd/A.
  • the organometallic complexes with the chemical structure of Structure I have a X 15 —N—X 16 —R 11 substructure which makes the complexes non-planar; as a result, the self-quenching effect of these complexes are low.
  • the self-quenching constant for the complexes of Structure I are in the order of 10 7 or lower, including, but not limited to, lower than in the order of 7 ⁇ 10 6 , 5 ⁇ 10 6 , 3 ⁇ 10 6 , 10 6 , 7 ⁇ 10 5 , 5 ⁇ 10 5 , 3 ⁇ 10 5 , or 10 5 .
  • the efficiency roll-off of the device at 1000 cd/A is less than 7%. In another embodiment, the efficiency roll-off of the device at 1000 cd/A is less than 20%, or any percentages lower than 20%, including, but not limited to, lower than 17%, 15%, 13%, 10%, 7%, 5%, or 3%.
  • a device shows no, or almost no, excimer emission with 10% doping concentration.
  • green to orange OLED can be fabricated by using the organometallic complex of Structure I as the single emitter.
  • a blue emitting material or layer is added to the orange device, and white OLED can be fabricated.
  • the device fabricated using the organometallic complex of Structure I shows green emission with CIE of (0.25 ⁇ 0.05, 0.63 ⁇ 0.05).
  • the device fabricated using the organometallic complex of Structure I shows yellow to orange emission with CIE of (0.40 ⁇ 0.1, 0.4 ⁇ 0.1).
  • organometallic complexes of Structure I do not carry net charge and are soluble in common solvents, various device fabrication methods can be used in OLED fabrication.
  • the luminescent platinum(II) compounds of the present invention can be formed into thin films by vacuum deposition, spin-coating, inkjet printing or other known fabrication methods.
  • Different multilayer OLEDs have been fabricated using the compounds of the present invention as light-emitting material or as dopant in the emitting layer.
  • the OLEDs consist on an anode and a cathode, between which are the hole transporting layer, light-emitting layer, and electron transporting or injection layer.
  • the present invention makes use of an additional carrier confinement layer to improve the performance of the devices.
  • the OLED is fabricated by vacuum deposition.
  • the OLED is fabricated by solution process including spin coating and printing.
  • Precursor 271 (1.31 g, 2.4 mmol), potassium tert-butoxide (0.33 g, 2.9 mmol), Pd(dba) 2 (0.22 g, 0.24 mmol), DPE-phos, 2-iodopyridine (0.26 g, 0.48 mmol), and anhydrous toluene.
  • the mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes.
  • Precursor 276 (0.65 g, 1.2 mmol), potassium tert-butoxide (0.17 g, 1.5 mmol), Pd(dba) 2 (0.11 g, 0.1 mmol), DPE-phos (0.13 g, 0.2 mmol), 2-iodopyridine (0.30 g, 1.2 mmol), and anhydrous toluene (20 mL).
  • the mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes.
  • the first intermediate (0.53 g, 1.4 mmol), potassium tert-butoxide (0.35 g, 3.1 mmol), 1-iodobutane (0.35 mL, 3.1 mmol), and anhydrous THF (20 mL).
  • the mixture was stirred for 24 h.
  • Precursor 218 (0.80 g, 2.28 mmol) and Precursor 228 (1.12 g, 2.28 mmol) was added 30 g ammonium acetate and 20 mL methanol. The mixture was refluxed overnight. The reaction mixture was partitioned with dichloromethane and water. The organics was dried with magnesium sulfate and evaporated under vacuum. The crude product was purified with column chromatography using dichloromethane as eluent. The product was obtained as a yellow solid. Yield: 0.75 g (1.22 mmol, 53%).
  • Precursor 248 (1.48 g, 5.16 mmol), potassium tert-butoxide (0.69 g, 6.19 mmol) and 50 mL anhydrous THF.
  • the mixture was stirred at room temperature for 2 hours under nitrogen atmosphere.
  • a solution of Precursor 253 (1.12 g, 5.16 mmol) in 50 mL THF was then added to the above mixture through a cannula.
  • the reaction mixture was stirred overnight at room temperature under nitrogen.
  • 50 g ammonium acetate and 25 mL glacial acetic acid The volatile organics was then removed by distillation at about 100° C.
  • Example 44 Photophysical Properties for Complexes 101, 102, 103, 105, 106, 107, 108, 109 and 129
  • OLEDs were fabricated on glass substrates with pre-patterned ITO electrodes.
  • the substrates were cleaned in an ultrasonic bath of detergent and deionized water, rinsed with deionized water, and then cleaned in sequential ultrasonic baths of dionized water, acetone, and isopropanol, and subsequently dried in an oven for 1 h.
  • the substrates were then transferred into a vacuum chamber, in which functional layers were in sequence deposited by thermal evaporation at a pressure of 10 ⁇ 6 -10 ⁇ 7 torr.
  • the thickness of the deposited material was monitored in situ using an oscillating quartz thickness monitor.
  • Finally a LiF buffer layer and Al cathode were vapor deposited onto the organic films.
  • EL spectra, luminance, and CIE coordination were measured by a Photo Research Inc PR-655. Voltage-current characteristics were measured by using a Keithley 2400 source measurement unit. All devices were characterized at room temperature in the atmosphere without encapsulation.
  • a device was fabricated according to Example 45 wherein four functional layers including MoO 3 (5 nm), CzSiCz (40 nm), CsPO 3 : Complex 101 (4%, 30 nm) and DPOSi (30 nm), which were used as hole-injection layer, hole-transporting layer, emissive layer and electron-transporting layer respectively, were deposited in sequence.
  • This device showed yellow emission with CIE coordinate of (0.42, 0.56), maximum current efficiency of 62.4 cd/A and efficiency roll-off of 11.9% at 1000 cd/m ⁇ 2 .
  • a device was fabricated according to Example 45 wherein four functional layers including MoO 3 (2 nm), DczSi (40 nm), CsPO1: Complex 101 (2%, 30 nm) and DPOSi (30 nm), which were used as hole-injection layer, hole-transporting layer, emissive layer and electron-transporting layer respectively, were deposited in sequence.
  • This device showed yellow emission with CIE coordinate of (0.39, 0.59), maximum current efficiency of 77.0 cd/A and efficiency roll-off of 5.2% at 1000 cd/m ⁇ 2 .
  • a device was fabricated with according to 45 wherein four functional layers including MoO 3 (5 nm), CzSiCz (40 nm), CsPO3: Complex 103 (2%, 30 nm) and DPOSi (30 nm), which were used as hole-injection layer, hole-transporting layer, emissive layer and electron-transporting layer respectively, were deposited in sequence.
  • This device showed green emission with CIE coordinate of (0.28, 0.61), maximum current efficiency of 43.6 cd/A and efficiency roll-off of 12.8% at 1000 cd/m ⁇ 2 .
  • a device was fabricated according to Example 45 wherein six functional layers including MoO 3 (5 nm), NPB (30 nm), TCTA (10 nm), TCTA: Complex 103 (10%, 15 nm), 1,3,5-tri(phenyl-2-benzimidazolyl)-benzene (TPBi): Complex 103 (10%, 15 nm) and TPBi (30 nm) which were used as hole-injection layer, hole-transporting layer, electron-blocking layer, emissive layer 1, emissive layer 2 and electron-transporting layer respectively, were deposited in sequence.
  • This device showed green emission with CIE coordinate of (0.27, 0.60), maximum current efficiency of 60.0 cd/A and efficiency roll-off of 33.3% at 1000 cd/m ⁇ 2 .
  • a device was fabricated according to Example 45 wherein six functional layers including MoO 3 (5 nm), NPB (30 nm), TCTA (10 nm), CBP: Complex 103 (7%, 15 nm), TAZ: Complex 103 (7%, 15 nm) and TAZ (30 nm) which were used as hole-injection layer, hole-transporting layer, electron-blocking layer, emissive layer 1, emissive layer 2 and electron-transporting layer respectively, were deposited in sequence.
  • This device showed green emission with CIE coordinate of (0.27, 0.60), maximum current efficiency of 78.0 cd/A and efficiency roll-off of 38.5% at 1000 cd/m ⁇ 2 .
  • OLEDs were fabricated on glass substrates with pre-patterned indium tin oxide (ITO) electrodes.
  • the substrates were cleaned in an ultrasonic bath of detergent and deionized water, rinsed with deionized water, and then cleaned in sequential ultrasonic baths of dionized water, acetone, and isopropanol, and subsequently dried in an oven for 1 h.
  • the solution processable functional layers were deposition in sequence by spin coating.
  • the samples were then then transferred into a vacuum chamber, in which the rest functional layers were in sequence deposited by thermal evaporation at a pressure of 10 ⁇ 6 -10 ⁇ 7 torr.
  • the thickness of the deposited material was monitored in situ using an oscillating quartz thickness monitor.
  • LiF buffer layer and Al cathode were vapor deposited onto the organic films.
  • EL spectra, luminance, and CIE coordination were measured by a Photo Research Inc PR-655.
  • Voltage-current characteristics were measured by using a Keithley 2400 source measurement unit. All devices were characterized at room temperature in the atmosphere without encapsulation.
  • a device was fabricated according to Example 51 wherein two solution processable functional layers including PEDOT: PPS and POSC1: Complex 101 (10%), which were used as hole-injection and hole-transporting layer and emissive layer respectively, were deposited by spin coated in sequenced. Afterward, a layer of TPBi (30 nm) was deposition by vacuum deposition as electron-transporting layer. This device showed yellow emission with CIE coordinate of (0.46, 0.54), maximum current efficiency of 35.0 cd/A and efficiency roll-off of 5.7% at 1000 cd/m ⁇ 2 .

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Electroluminescent Light Sources (AREA)

Abstract

The current invention relates to novel platinum(II) based organometallic materials. These materials show high emission quantum efficiencies and low self-quenching constant. Also provided are high efficiency, green to orange emitting organic light-emitting diode (OLED) that are fabricated using platinum(II) based organometallic materials as the light-emitting material. The organometallic materials of the invention are soluble in common solvents; therefore, solution process methods such as spin coating and printing can be used for device fabrication. The devices fabricated from these materials show low efficiency roll-off.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
The subject application is a divisional application which claims the benefit of U.S. application Ser. No. 13/861,119, filed Apr. 11, 2013, which claims the benefit of U.S. Provisional Application Ser. No. 61/623,339, filed Apr. 12, 2012, which are incorporated herein by reference in their entirety.
TECHNICAL FIELD
The present invention relates to a class platinum(II) complexes, their preparation methods, and their applications in organic light-emitting diodes (OLED).
BACKGROUND
As organic light-emitting diodes (OLEDs) are recognized as the next-generation display and lighting technology, OLED related technologies are rapidly developing. Organic-based emitting material is one of the most important core technologies in OLED; therefore, much effort has been devoted to this area. Since triplet emitters could fully utilize all excitons generated in the device, they are the focus in the field of emissive material development.
The idea of using phosphorescent materials in OLED was independently introduced by Baldo et al., Ma, and Che et al. in 1998. The world's first phosphorescent OLED (P-OLED) was fabricated using phosphorescent platinum(II) complex [Pt(OEP)] (OEP=octaethylporphin) (Nature 1998, 395, 151-154) and osmium(II) complex [Os(CN)2(PPh3)(X)] (X=4,4′-diphenyl-2,2′-bipyridine) (Synth. Met. 1998, 94, 245-248) as emitting materials respectively. High efficiency P-OLEDs have continuously been fabricated from new phosphorescent materials and are useful in various mobile electronics devices such as cellphones.
Although the phosphorescent materials that are currently used in the OLED industry have high emissive quantum efficiency (more than 60%), improved phosphorescent materials are needed. As a result, continuous attempts have been made in the development of new materials, especially blue-emitting materials.
In addition, most P-OLEDs suffer from high roll-off. In the cases of platinum containing materials, more than 90% roll-off is observed in 1,000 cd/m2 (Applied Physics Letter 92, 163305 (2008), Chemical Communications 2005, 1408-1410, Chemical Communications 2004, 1484-1485, Applied Physics Letter 91, 063508 (2007), Chemistry A European Journal 2010, 16, 233-247). This problem of high efficiency roll-off is due to triplet-triplet annihilation and/or excimer formation. To solve this problem, previous researchers added bulky groups such as tert-butyl groups in the emissive molecules; nevertheless, the P-OLEDs fabricated from these materials still have more than 50% roll-off (Applied Physics Letter 91, 063508 (2007), Advanced Material 2007, 19, 3599-3603).
BRIEF SUMMARY
This present invention relates to novel platinum(II)-based materials having the chemical structure of Structure I. Also provided are methods of preparing the platinum(II)-based materials, and their applications in organic light-emitting diode (OLED).
In one embodiment, the platinum(II)-based compounds of Structure I are shown as follows:
Figure US10008681-20180626-C00001
wherein R1-R15 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group;
wherein each pair of adjacent R groups of R1-R15 can be independently two separated groups (or atoms) or one group (or atom), and fonn 5-8 member ring(s) with 2 to 4 X groups; and
wherein X1-X20 are independently boron, carbon, nitrogen, oxygen, silicon, germanium, phosphorous, sulphur or selenium.
In one embodiment, the platinum(II) center is surrounded by the ligands featuring with a 6-5-6 fused membered ring system (the bolded line in structure I).
In one embodiment, R11 is aryl or substituted aryl group, and R10 can be one of the carbon atoms on R11, thereby forming a 6-5-6 fused ring system with the adjacent aryl ring.
The present invention also provides devices fabricated from the platinum(II)-based compounds of Structure I. Advantageously, the devices of the invention exhibit high efficiency and low roll-off.
BRIEF DESCRIPTION OF DRAWING
FIG. 1 shows one embodiment of the synthetic scheme of the platinum(II)-based organometallic compounds of Structure I. In an exemplified embodiment, the compound of Structure I is prepared using a ligand of Structure II. For the Precursors 210 to 280 and the compound of Structure II, R1-R16 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group; and X1-X21 are independently boron, carbon, nitrogen, oxygen, silicon, germanium, phosphorous, sulphur or selenium. In certain embodiments, each pair of adjacent R groups of R1-R16 can be independently two separated groups (or atoms) or one group (or atom), and form 5-8 member ring(s) with 2 to 4 X groups.
FIG. 2 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 1.
FIG. 3 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 2.
FIG. 4 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 3.
FIG. 5 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 4.
FIG. 6 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 5.
FIG. 7 shows the current density-voltage-brightness (J-B-V) relationship and efficiency-voltage curves of OLED 6.
 DETAILED DESCRIPTION Definitions
To facilitate the understanding of the subject matter disclosed herein, a number of terms, abbreviations or other shorthand as used herein are defined below. Any term, abbreviation or shorthand not defined is understood to have the ordinary meaning used by a skilled artisan contemporaneous with the submission of this application.
“Amino” refers to a primary, secondary, or tertiary amine which may be optionally substituted. Specifically included are secondary or tertiary amine nitrogen atoms which are members of a heterocyclic ring. Also specifically included, for example, are secondary or tertiary amino groups substituted by an acyl moiety. Some non-limiting examples of an amino group include —NR′R″ wherein each of R′ and R″ is independently H, alkyl, aryl, aralkyl, alkaryl, cycloalkyl, acyl, heteroalkyl, heteroaryl or heterocycyl.
“Alkyl” refers to a fully saturated acyclic monovalent radical containing carbon and hydrogen, and which may be branched or a straight chain. Examples of alkyl groups include, but are not limited to, methyl, ethyl, n-propyl, isopropyl, n-butyl, t-butyl, n-heptyl, n-hexyl, n-octyl, and n-decyl.
“Alkylamino” means a radical —NHR or —NR2 where each R is independently an alkyl group. Representative examples of alkylamino groups include, but are not limited to, methylamino, (1-methylethyl)amino, methylamino, dimethyl amino, methylethylamino, and di(1-methyethyl)amino.
The term “hydroxyalkyl” means an alkyl radical as defined herein, substituted with one or more, preferably one, two or three hydroxy groups. Representative examples of hydroxyalkyl include, but are not limited to, hydroxymethyl, 2-hydroxyethyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-(hydroxymethyl)-2-methylpropyl, 2-hydroxybutyl, 3-hydroxybutyl, 4-hydroxybutyl, 2,3-dihydroxypropyl, 2-hydroxy-1-hydroxymethylethyl, 2,3-dihydroxybutyl, 3,4-dihydroxybutyl and 2-(hydroxymethyl)-3-hydroxy-propyl, preferably 2-hydroxyethyl, 2,3-dihydroxypropyl, and 1-(hydroxymethyl)2-hydroxyethyl.
The term “alkoxy,” as used herein, refers the radical —ORx. Exemplary alkoxy groups include, but are not limited to, methoxy, ethoxy, and propoxy.
“Aromatic” or “aromatic group” refers to aryl or heteroaryl.
“Aryl” refers to optionally substituted carbocyclic aromatic groups. In some embodiments, the aryl group includes phenyl, biphenyl, naphthyl, substituted phenyl, substituted biphenyl or substituted naphthyl. In other embodiments, the aryl group is phenyl or substituted phenyl.
“Aralkyl” refers to an alkyl group which is substituted with an aryl group. Some non-limiting examples of aralkyl include benzyl and phenethyl.
“Acyl” refers to a monovalent group of the formula —C(═O)H, —C(═O)-alkyl, —C(═O)-aryl, —C(═O)-aralkyl, or —C(═O)-alkaryl.
“Halogen” refers to fluorine, chlorine, bromine and iodine.
“Styryl” refers to a univalent radical C6H5—CH═CH— derived from styrene.
“Substituted” as used herein to describe a compound or chemical moiety refers to that at least one hydrogen atom of that compound or chemical moiety is replaced with a second chemical moiety. Non-limiting examples of substituents are those found in the exemplary compounds and embodiments disclosed herein, as well as halogen; alkyl; heteroalkyl; alkenyl; alkynyl; aryl; heteroaryl; hydroxy; alkoxyl; amino; nitro; thiol; thioether; imine; cyano; amido; phosphonato; phosphine; carboxyl; thiocarbonyl; sulfonyl; sulfonamide; ketone; aldehyde; ester; oxo; haloalkyl (e.g., trifluoromethyl); carbocyclic cycloalkyl, which can be monocyclic or fused or non-fused polycyclic (e.g., cyclopropyl, cyclobutyl, cyclopentyl or cyclohexyl) or a heterocycloalkyl, which can be monocyclic or fused or non-fused polycyclic (e.g., pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl or thiazinyl); carbocyclic or heterocyclic, monocyclic or fused or non-fused polycyclic aryl (e.g., phenyl, naphthyl, pyrrolyl, indolyl, furanyl, thiophenyl, imidazolyl, oxazolyl, isoxazolyl, thiazolyl, triazolyl, tetrazolyl, pyrazolyl, pyridinyl, quinolinyl, isoquinolinyl, acridinyl, pyrazinyl, pyridazinyl, pyrimidinyl, benzimidazolyl, benzothiophenyl or benzofuranyl); amino (primary, secondary or tertiary); o-lower alkyl; o-aryl, aryl; aryl-lower alkyl; —CO2CH3; —CONH2; —OCH2CONH2; —NH2; SO2NH2; —OCHF2; —CF3; —OCF3; —NH(alkyl); —N(alkyl)2; —NH(aryl); —N(alkyl)(aryl); N(aryl)2; —CHO; —CO(alkyl); CO(aryl); —CO2(alkyl); and −CO2(aryl); and such moieties can also be optionally substituted by a fused-ring structure or bridge, for example —OCH2O—. These substituents can optionally be further substituted with a substituent selected from such groups. All chemical groups disclosed herein can be substituted, unless it is specified otherwise. For example, “substituted” alkyl, alkenyl, alkynyl, aryl, hydrocarbyl or heterocyclo moieties described herein are moieties which are substituted with a hydrocarbyl moiety, a substituted hydrocarbyl moiety, a heteroatom, or a heterocyclo. Further, substituents may include moieties in which a carbon atom is substituted with a heteroatom such as nitrogen, oxygen, silicon, phosphorus, boron, sulfur, or a halogen atom. These substituents may include halogen, heterocyclo, alkoxy, alkenoxy, alkynoxy, aryloxy, hydroxy, protected hydroxy, keto, acyl, acyloxy, nitro, amino, amido, cyano, thiol, ketals, acetals, esters and ethers.
Light-Emitting Platinum(II)-Based Organometallic Complex
In one aspect, the present invention provides platinum(II)-based organometallic compounds. In one embodiment, an organometallic complex represented by Structure I, also referred herein as cyclometallated complexes, is provided. The platinum center in Structure I is in +2 oxidation state and has a square planar geometry. The coordination sites of the platinum center are occupied by a tetradentate ligand. The tetradentate ligand featuring with 6-5-6 fused membered rings coordinates to the platinum center through a metal-oxygen bond, a nitrogen donor bond, a metal-carbon bond and a nitrogen donor bond in a sequence of O, N, C, N (O^N^C*N ligand; i.e., 4 connecting covalent bonds (either single or double) between O^N, 3 connecting covalent bonds (either single or double) between N^C, 4 connecting covalent bonds (either single or double) between C*N). The metal-oxygen bond is a bond between deprotonated phenol or substituted phenol and platinum, the nitrogen donors are from pyridine and/or isoquinoline groups, and the metal-carbon bond is formed by benzene or substituted benzene and platinum.
In one embodiment, the platinum(II)-based organometallic compounds have the chemical structure of Structure I
Figure US10008681-20180626-C00002
wherein R1-R15 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group;
wherein each pair of adjacent R groups of R1-R15 can be independently two separated groups (or atoms) or one group (or atom), and form 5-8 member ring(s) with 2 to 4 X groups; and
wherein X1-X20 are independently boron, carbon, nitrogen, oxygen, silicon, germanium, phosphorous, sulphur or selenium.
In one embodiment, the platinum(II) center is surrounded by the ligands featuring with a 6-5-6 fused membered ring system (the bolded line in structure I).
In one embodiment, R11 is aryl or substituted aryl group, and R10 can be one of the carbon atoms on R11 thereby forming a 6-5-6 fused ring system with the adjacent aryl ring.
In one embodiment, each R1-R15 is independently hydrogen, halogen (such as fluorine, chlorine bromine, and iodine), hydroxyl, an unsubstituted alkyl containing from 1 to 10 carbon atoms, a substituted alkyl containing from 1 to 20 carbon atoms, cycloalkyl containing from 4 to 20 carbon atoms, an unsubstituted aryl containing from 6 to 20 carbon atoms, a substituted aryl containing from 6 to 20 carbon atoms, acyl containing from 1 to 20 carbon atoms, alkoxy containing from 1 to 20 carbon atoms, acyloxy containing from 1 to 20 carbon atoms, amino, nitro, acylamino containing from 1 to 20 carbon atoms, aralkyl containing from 1 to 20 carbon atoms, cyano, carboxyl containing from 1 to 20 carbon atoms, thiol, styryl, aminocarbonyl containing from 1 to 20 carbon atoms, carbamoyl containing from 1 to 20 carbon atoms, aryloxycarbonyl containing from 1 to 20 carbon atoms, phenoxycarbonyl containing from 1 to 20 carbon atoms, or an alkoxycarbonyl group containing from 1 to 20 carbon atoms.
In another embodiment, the total number of carbon atoms provided by the R1-R15 groups is from 1 to 40.
In another embodiment, the total number of carbon atoms provided by the R1-R15 groups is from 2 to 30.
Certain specific, non-limiting examples of the organometallic complexes with Structure I are shown as follows:
Figure US10008681-20180626-C00003
Figure US10008681-20180626-C00004
Figure US10008681-20180626-C00005
Figure US10008681-20180626-C00006
Figure US10008681-20180626-C00007
Figure US10008681-20180626-C00008
Figure US10008681-20180626-C00009
Figure US10008681-20180626-C00010
Preparation of Platinum(II)-Based Organometallic Complex
In one embodiment, the organometallic complex with the chemical structure of Structure I can be prepared from a tetradentate ligand with a chemical structure of Structure II:
Figure US10008681-20180626-C00011
wherein R1-R15 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group;
wherein each pair of adjacent R groups of R1-R15 can be independently two separated groups (or atoms) or one group (or atom), and form 5-8 member ring(s) with 2 to 4 X groups; and
wherein X1-X20 are independently boron, carbon, nitrogen, oxygen, silicon, germanium, phosphorous, sulphur or selenium.
In one embodiment, R11 is aryl or substituted aryl group, and R10 can be one of the carbon atoms on R11 thereby forming a 6-5-6 fused ring system with the adjacent aryl ring.
In one embodiment, each R1-R15 is independently hydrogen, halogen (such as fluorine, chlorine bromine, and iodine), hydroxyl, an unsubstituted alkyl containing from 1 to 10 carbon atoms, a substituted alkyl containing from 1 to 20 carbon atoms, cycloalkyl containing from 4 to 20 carbon atoms, an unsubstituted aryl containing from 6 to 20 carbon atoms, a substituted aryl containing from 6 to 20 carbon atoms, acyl containing from 1 to 20 carbon atoms, alkoxy containing from 1 to 20 carbon atoms, acyloxy containing from 1 to 20 carbon atoms, amino, nitro, acylamino containing from 1 to 20 carbon atoms, aralkyl containing from 1 to 20 carbon atoms, cyano, carboxyl containing from 1 to 20 carbon atoms, thio, styryl, aminocarbonyl containing from 1 to 20 carbon atoms, carbamoyl containing from 1 to 20 carbon atoms, aryloxycarbonyl containing from 1 to 20 carbon atoms, phenoxycarbonyl containing from 1 to 20 carbon atoms, or an alkoxycarbonyl group containing from 1 to 20 carbon atoms.
In another embodiment, the total number of carbon atoms provided by the R1-R15 groups is from 1 to 40.
In another embodiment, the total number of carbon atoms provided by the R1-R15 groups is from 2 to 30.
Certain specific non-limiting examples of the tetradentate ligand with Structure II are shown below:
Figure US10008681-20180626-C00012
Figure US10008681-20180626-C00013
Figure US10008681-20180626-C00014
Figure US10008681-20180626-C00015
Figure US10008681-20180626-C00016
Figure US10008681-20180626-C00017
Figure US10008681-20180626-C00018
Figure US10008681-20180626-C00019
In one embodiment, the tetradentate ligands with Structure II can be prepared by a series of reactions depicted in FIG. 1.
According to FIG. 1, Precursor 210 reacts with Precursor 220 or Precursor 230 reacts with Precursor 240, through Reaction 301 to form Precursor 260 or through Reaction 302 to form Precursor 280, depending on the chemical structure of the Precursor 210-Precursor 240. If Precursor 260 is produced, it is transformed to Precursor 270 through Reaction 305 and then transformed to Precursor 280 through Reaction 306. Finally, Precursor 208 is transformed to a ligand with a chemical structure of Structure II by Reaction 307. Precursor 260 and Precursor 280 can also be produced by reacting Precursor 240 with Precursor 250 through Reaction 303 or Reaction 304. All reactions 301-307 can be a single step or multi-step reaction.
In one embodiment, Reaction 301 comprises reacting Precursor 210 and Precursor 220 or Precursor 230 and Precursor 240. In one embodiment, Reaction 301 is performed in the presence of excess ammonium acetate and a solvent under a reflux condition. Suitable solvents for Reaction 301 include, but are not limited to, methanol. In one embodiment, Reaction 305 comprises a palladium coupling reaction using bis[2-(diphenylphoshpine)phenyl]ether (DPE-phos) as a ligand, tris(dibenzylideneacetone)dipalladium(0) as the catalyst, potassium tert-butoxide as the base and toluene as the solvent, under an inert nitrogen environment at 80° C.
In one embodiment, Reaction 306 is the same as Reaction 305.
In one embodiment, Reaction 307 comprises reacting pyridine hydrogen chloride with Precursor 280.
In one embodiment, Reaction 307 comprises reacting carbon tetarbromide with Precursor 280.
In another embodiment, the present invention provides a method of preparing the organometallic complex with chemical structure of Structure I, comprising reacting a ligand with chemical structure of Structure II with a platinum(II) salt in the presence of solvent(s). Other chemicals such as based will be added if they are needed in the reaction. In one embodiment, the platinum(II) salt is potassium tetrachloroplatinate. In another embodiment, the solvents are glacial acetic acid and chloroform.
Industrial Applications of Platinum(II) Based Organometallic Complexes
The platinum(II) based organometallic complexes having the chemical structure of Structure I show strong emission with high solution quantum yield.
As the platinum(II) based organometallic complexes of Structure I have a rigid structure which reduces the non-radioactive decay, the emission quantum efficiency of these complexes are high. Therefore, high efficiency organic light emitting diode (OLED) can be fabricated by using these complexes as emitting material.
In one embodiment, the OLED fabricated using the organometallic complex of Structure I shows a high efficiency of greater than 70 cd/A. In another embodiment, the OLED fabricated using the organometallic complex of Structure I shows a high efficiency of greater than 40 cd/A, including, but not limited to, greater than 45 cd/A, 50 cd/A, 55 cd/A, 60 cd/A, 65 cd/A, 70 cd/A, 75 cd/A, 80 cd/A, or 85 cd/A.
In one embodiment, the organometallic complexes with the chemical structure of Structure I have a X15—N—X16—R11 substructure which makes the complexes non-planar; as a result, the self-quenching effect of these complexes are low. In one embodiment, the self-quenching constant for the complexes of Structure I are in the order of 107 or lower, including, but not limited to, lower than in the order of 7×106, 5×106, 3×106, 106, 7×105, 5×105, 3×105, or 105.
The effect of triplet-triplet annihilation in the devices is suppressed. As a result, the efficiency roll-off in the devices fabricated by using these complexes as emitting materials are low.
In one embodiment, the efficiency roll-off of the device at 1000 cd/A is less than 7%. In another embodiment, the efficiency roll-off of the device at 1000 cd/A is less than 20%, or any percentages lower than 20%, including, but not limited to, lower than 17%, 15%, 13%, 10%, 7%, 5%, or 3%.
Furthermore, due to the low self-quenching, higher doping concentration can be used to increase the device efficiency while the CIE can be kept as the excimer emission is avoided, or is substantially avoided.
In one embodiment, a device shows no, or almost no, excimer emission with 10% doping concentration.
As the complexes show emission from green to orange region, green to orange OLED can be fabricated by using the organometallic complex of Structure I as the single emitter. In an embodiment, a blue emitting material (or layer) is added to the orange device, and white OLED can be fabricated.
In one embodiment, the device fabricated using the organometallic complex of Structure I shows green emission with CIE of (0.25±0.05, 0.63±0.05).
In another embodiment, the device fabricated using the organometallic complex of Structure I shows yellow to orange emission with CIE of (0.40±0.1, 0.4±0.1).
Since the organometallic complexes of Structure I do not carry net charge and are soluble in common solvents, various device fabrication methods can be used in OLED fabrication.
The luminescent platinum(II) compounds of the present invention can be formed into thin films by vacuum deposition, spin-coating, inkjet printing or other known fabrication methods. Different multilayer OLEDs have been fabricated using the compounds of the present invention as light-emitting material or as dopant in the emitting layer. In general, the OLEDs consist on an anode and a cathode, between which are the hole transporting layer, light-emitting layer, and electron transporting or injection layer. The present invention makes use of an additional carrier confinement layer to improve the performance of the devices.
In one embodiment, the OLED is fabricated by vacuum deposition.
In another embodiment, the OLED is fabricated by solution process including spin coating and printing.
EXAMPLES
Following are examples that illustrate embodiments for practicing the invention. These examples should not be construed as limiting. All percentages are by weight and all solvent mixture proportions are by volume unless otherwise noted.
Example 1—Preparation of Precursor 261
Figure US10008681-20180626-C00020
To a conical flask was charged with Precursor 221 (2.24 g, 5.5 mmol), Precursor 211 (1.95 g, 5.5 mmol), excess ammonium acetate, and methanol. The mixture was refluxed for 24 h. After cooling to room temperature, the solvent was evaporated. The crude mixture was extracted with dichloromethane and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 2.56 g of off-white solid was obtained. Yield: 88%. 1H NMR (CDCl3, 400 MHz): δ 8.31 (s, 1H), 8.05-8.04 (m, 2H), 8.01 (d, J=7.6 Hz, 1H), 7.78 (s, 1H), 7.55-7.53 (m, 2H), 7.52 (s, 2H), 7.42 (t, J=7.3 Hz, 1H), 7.36 (t, J=7.9 Hz, 1H), 7.15 (t, J=7.5 Hz, 1H), 7.05 (d, J=8.2 Hz, 1H), 3.90 (s, 3H), 1.41 (s, 18H).
Example 2—Preparation of Precursor 271
Figure US10008681-20180626-C00021
To a dry, nitrogen-flushed flask was charged with Precursor 261 (1.44 g, 2.7 mmol), potassium tert-butoxide (0.42 g, 3.8 mmol), Pd(dba)2 (0.25 g, 0.27 mmol), DPE-phos(bis[2-(diphenylphosphino)phenyl]ether) (0.29 g, 0.55 mmol), aniline (0.25 g, 2.7 mmol), and anhydrous toluene. The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 1.31 g of yellow solid was obtained. Yield: 90%. 1H NMR (CDCl3, 400 MHz): δ 8.03 (s, 2H), 7.88 (s, 1H), 7.79 (s, 1H), 7.62 (m, 1H), 7.53 (s, 3H), 7.42-7.39 (m, 2H), 7.38-7.36 (m, 1H), 7.30-7.28 (m, 2H), 7.13-7.11 (m, 2H), 7.05-7.03 (m, 2H), 6.93 (m, 1H), 5.86 (s, 1H), 3.89 (s, 3H), 1.40 (s, 18H).
Example 3—Preparation of Precursor 281
Figure US10008681-20180626-C00022
To a dry, nitrogen-flushed flask was charged with Precursor 271 (1.31 g, 2.4 mmol), potassium tert-butoxide (0.33 g, 2.9 mmol), Pd(dba)2 (0.22 g, 0.24 mmol), DPE-phos, 2-iodopyridine (0.26 g, 0.48 mmol), and anhydrous toluene. The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 1.29 g of yellow solid was obtained. Yield: 87%. 1H NMR (CDCl3, 400 MHz): δ 8.26 (d, J=4.92 Hz, 1H), 8.01 (s, 1H), 7.96 (d, J=7.6 Hz, 1H), 7.93-7.89 (m, 2H), 7.70 (s, 1H), 7.52 (t, J=1.97 Hz, 1H), 7.49 (s, 2H), 7.45-7.23 (m, 8H), 7.11 (q, J=7.5 Hz, 2H), 7.03 (d, J=8.2 Hz, 1H), 6.84 (d, J=8.4 Hz, 1H), 6.78-6.80 (m, 1H), 3.86 (s, 3H), 1.38 (s, 18H).
Example 4—Preparation of Ligand 401
Figure US10008681-20180626-C00023
To a dry, nitrogen-flushed flask was charged with Precursor 281 (1.29 g, 2.1 mmol) and pyridine hydrochloride. The mixture was refluxed for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 1.2 g of yellow solid was obtained. Yield: 95%. 1H NMR (CD2Cl2, 500 MHz): δ 14.37 (s, 1H), 8.22 (d, J=4.9 Hz, 1H), 8.05 (s, 1H), 7.96 (d, J=8.1 Hz, 1H), 7.78 (s, 1H), 7.75 (d, J=7.7 Hz, 1H), 7.72 (s, 1H), 7.58 (s, 1H), 7.52-7.48 (m, 4H), 7.38-7.31 (m, 3H), 7.28-7.24 (m, 3H), 7.19 (t, J=5.8 Hz, 1H), 6.99 (d, J=8.3 Hz, 1H), 6.95 (t, J=7.5 Hz, 1H), 6.82-6.86 (m, 2H), 1.39 (s, 18H). MS (FAB): 604.1 (M+)
Example 5—Preparation of Precursor 282
Figure US10008681-20180626-C00024
To a dry, nitrogen-flushed flask was charged with Precursor 271 (0.20 g, 0.37 mmol), potassium tert-butoxide (0.05 g, 0.44 mmol), Pd(dba)2 (0.03 g, 0.03 mmol), DPE-phos (0.04 g, 0.07 mmol), 3-bromoisoquinoline (0.08 g, 0.86 mmol), and anhydrous toluene. The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.17 g of yellow solid was obtained. Yield: 69%. 1H NMR (CDCl3, 300 MHz): δ 9.03 (s, 1H), 8.00 (s, 1H), 7.83-7.96 (m, 4H), 7.69 (s, 1H), 7.53-7.45 (m, 6H), 7.39-7.30 (m, 5H), 7.25-7.23 (m, 2H), 7.15-7.02 (m, 4H), 3.85 (s, 3H), 1.37 (s, 18H).
Example 6—Preparation of Ligand 402
Figure US10008681-20180626-C00025
To a dry, nitrogen-flushed flask was charged with Precursor 282 (0.13 g, 0.19 mmol) and pyridine hydrochloride. The mixture was refluxed for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.11 g of yellow solid was obtained. Yield: 90%. 1H NMR (CD2Cl2, 400 MHz): δ14.67 (s, 1H), 9.04 (s, 1H), 7.97 (s, 1H), 7.89-7.84 (m, 2H), 7.73-7.71 (m, 2H), 7.63 (s, 1H), 7.55-7.53 (m, 3H), 7.47-7.44 (m, 3H), 7.38-7.26 (m, 7H), 7.17-7.15 (m, 2H), 7.02 (d, J=8.1 Hz, 1H), 6.94 (t, J=8.1 Hz, 1H), 1.38 (s, 18H).
Example 7—Preparation of Precursor 253
Figure US10008681-20180626-C00026
To a conical flask was charged with 7-methoxy-1-indanone (2.18 g, 13.4 mmol), 1,1-dimethoxy-N,N-dimethylmethanamine. The mixture was refluxed for 24 h. After cooling to room temperature, the solvent was evaporated. The crude mixture was purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 2.42 g of brown solid was obtained. Yield: 83%. 1H NMR (CDCl3, 300 MHz): δ 7.42-7.37 (m, 2H), 7.00 (d, J=7.5 Hz, 1H), 6.79 (d, J=8.2 Hz, 1H), 3.95 (s, 3H), 3.85 (s, 2H), 3.14 (s, 6H).
Example 8—Preparation of Precursor 263
Figure US10008681-20180626-C00027
To a dry, nitrogen-flushed flask was charged with Precursor 253 (2.18 g, 10.0 mmol), Precursor 243 (1.99 g, 10.0 mmol), potassium tert-butoxide (1.35 g, 12.0 mmol), anhydrous THF. The mixture was stirred for 12 h. Excess ammonium acetate, acidic acid was added. The mixture was refluxed for 2 h. After cooling to room temperature, the crude mixture was extracted with ethyl acetate and an intermediate was purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). To a dry, nitrogen-flushed flask was charged the intermediate prepared above (0.53 g, 1.5 mmol), potassium tert-butoxide (0.37 g, 3.3 mmol), 1-iodobutane (0.38 mL, 3.3 mmol), and anhydrous THF. The mixture was stirred for 24 h. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.60 g of yellow solid was obtained. Yield: 77%. 1H NMR (CDCl3, 400 MHz): δ 8.38 (s, 1H), 8.10 (d, J=7.8 Hz, 1H), 7.63 (q, J=7.9 Hz, 2H), 7.51 (d, J=8.0 Hz, 1H), 7.42-7.32 (m, 2H), 7.00 (d, J=7.6 Hz, 1H), 6.93 (d, J=8.0 Hz, 1H), 4.11 (s, 3H), 2.01-1.96 (s, 4H), 1.10-1.02 (m, 4H), 0.67-0.57 (m, 10H).
Example 9—Preparation of Precursor 273
Figure US10008681-20180626-C00028
To a dry, nitrogen-flushed flask was charged with Precursor 263 (0.54 g, 1.2 mmol), potassium tert-butoxide (0.16 g, 1.4 mmol), Pd(dba)2 (0.11 g, 0.12 mmol), DPE-phos(bis[2-(diphenylphosphino)phenyl]ether) (0.13 g, 0.23 mmol), aniline (0.11 g, 1.2 mmol), and anhydrous toluene. The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.41 g of yellow solid was obtained. Yield: 74%. 1H NMR (CDCl3, 300 MHz): δ 8.00 (s, 1H), 7.69 (d, J=7.8 Hz, 1H), 7.62 (s, 2H), 7.41-7.33 (m, 3H), 7.30 (s, 1H), 7.15-7.13 (m, 3H), 7.00-6.90 (m, 3H), 5.82 (s, 1H), 4.05 (s, 3H), 2.00-1.95 (m, 4H), 1.10-1.02 (m, 4H), 0.67-0.57 (m, 10H).
Example 10—Preparation of Precursor 283
Figure US10008681-20180626-C00029
To a dry, nitrogen-flushed flask was charged with Precursor 273 (0.41 g, 0.86 mmol), potassium tert-butoxide (0.12 g, 1.03 mmol), Pd(dba)2 (0.08 g, 0.086 mmol), DPE-phos (0.09 g, 0.17 mmol), 2-iodopyridine (0.18 g, 0.86 mmol), and anhydrous toluene. The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.43 g of yellow solid was obtained. Yield: 90%. 1H NMR (CDCl3, 400 MHz): δ8.26 (d, J=7.7 Hz, 1H), 8.05 (s, 1H), 7.93 (d, J=7.9 Hz, 1H), 7.60 (d, J=7.8 Hz, 2H), 7.55 (d, J=8.0 Hz, 1H), 7.45 (q, J=8.3 Hz, 2H), 7.38-7.30 (m, 4H), 7.23-7.20 (m, 2H), 7.11 (t, J=7.0 Hz, 1H), 6.97 (d, J=7.5 Hz, 1H), 6.85 (d, J=8.0 Hz, 1H), 6.81 (d, J=7.7 Hz, 1H), 6.78 (t, J=6.5 Hz, 1H), 3.95 (s, 3H), 1.97-1.55 (m, 4H), 1.07-1.00 (m, 4H), 0.65-0.53 (m, 10H).
Example 11—Preparation of Ligand 403
Figure US10008681-20180626-C00030
To a dry, nitrogen-flushed flask was charged with Precursor 283 (0.43 g, 0.77 mmol) and pyridine hydrochloride. The mixture was refluxed for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.387 g of yellow solid was obtained. Yield: 90%. 1H NMR (CD2Cl2, 500 MHz): δ 9.17 (s, 1H), 8.21 (d, J=5.2 Hz, 1H), 7.83 (s, 1H), 7.79 (d, J=8.0 Hz, 1H), 7.68 (d, J=7.9 Hz, 1H), 7.54 (d, J=7.9 Hz, 1H), 7.50 (t, J=7.8 Hz, 1H), 7.45 (t, J=7.9 Hz, 1H), 7.36 (t, J=7.9 Hz, 2H), 7.31 (t, J=7.9 Hz, 1H), 7.25-7.21 (m, 3H), 7.18 (t, J=7.4 Hz, 1H), 6.93 (d, J=7.3 Hz, 1H), 6.84-6.82 (m, 3H), 1.97-1.92 (m, 4H), 1.10-1.06 (m, 4H), 0.71-0.66 (m, 10H). MS(FAB): 540.3 (M+).
Example 12—Preparation of Precursor 284
Figure US10008681-20180626-C00031
To a dry, nitrogen-flushed flask was charged with Precursor 273 (0.21 g, 0.44 mmol), potassium tert-butoxide (0.06 g, 0.52 mmol), Pd(dba)2 (0.04 g, 0.04 mmol), DPE-phos (0.05 g, 0.08 mmol), 3-bromoisoquinoline (0.09 g, 0.44 mmol), and anhydrous toluene. The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.17 g of yellow solid was obtained. Yield: 65%. 1H NMR (CDCl3, 400 MHz): δ 9.03 (s, 1H), 8.05 (s, 1H), 7.95 (d, J=7.6 Hz, 1H), 7.84 (d, J=8.1 Hz, 1H), 7.60-7.50 (m, 5H), 7.46 (t, J=7.9 Hz, 1H), 7.37-7.31 (m, 5H), 7.25-7.23 (m, 2H), 7.12 (s, 1H), 6.96 (d, J=7.4 Hz, 1H), 6.84 (d, J=8.1 Hz, 1H), 3.84 (s, 3H), 1.97-1.92 (m, 4H), 1.06-1.01 (m, 4H), 0.64-0.57 (m, 10H).
Example 13—Preparation of Ligand 404
Figure US10008681-20180626-C00032
To a dry, nitrogen-flushed flask was charged with Precursor 284 (0.17 g, 0.28 mmol) and pyridine hydrochloride. The mixture was refluxed for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.15 g of yellow solid was obtained. Yield: 90%. 1H NMR (CDCl3, 300 MHz): δ 9.31 (s, 1H), 9.04 (s, 1H), 7.86 (d, J=8.5 Hz, 1H), 7.80 (s, 2H), 7.54-7.45 (m, 5H), 7.42-7.31 (m, 3H), 7.29-7.23 (m, 4H), 7.15 (s, 2H), 6.87 (t, J=8.7 Hz, 2H), 1.96-1.91 (m, 4H), 1.05-1.00 (m, 4H), 0.70-0.65 (m, 10H). MS(ESI): 590.3 (M+).
Example 14—Preparation of Precursor 265
Figure US10008681-20180626-C00033
To a dry, nitrogen-flushed flask was charged with Precursor 253 (0.50 g, 2.3 mmol), Precursor 245 (0.54 g, 2.3 mmol), potassium tert-butoxide (0.31 g, 2.7 mmol), anhydrous THF. The mixture was stirred for 12 h. Excess ammonium acetate, acidic acid was added. The mixture was refluxed for 2 h. After cooling to room temperature, the crude mixture of the intermediate was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1).
To a dry, nitrogen-flushed flask was the above intermediate (0.90 g, 2.3 mmol), potassium tert-butoxide (0.57 g, 5.1 mmol), 1-iodobutane (0.58 mL, 5.1 mmol), and anhydrous THF. The mixture was stirred for 24 h. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 1.04 g of yellow solid was obtained. Yield: 81%. 1H NMR (CDCl3, 400 MHz): δ 8.65 (t, J=8.1 Hz, 1H), 7.70 (d, J=7.9 Hz, 1H), 7.65 (d, J=7.8 Hz, 1H), 7.41 (t, J=8.0 Hz, 1H), 7.02-6.94 (m, 3H), 4.11 (s, 3H), 2.02-1.96 (m, 4H), 1.10-1.04 (m, 4H), 0.68-0.56 (m, 10H).
Example 15—Preparation of Precursor 275
Figure US10008681-20180626-C00034
To a dry, nitrogen-flushed flask was charged with Precursor 265 (1.22 g, 2.4 mmol), potassium phosphate (0.78 g, 3.6 mmol), Pd(dba)2 (0.22 g, 0.2 mmol), DPE-phos(bis[2-(diphenylphosphino)phenyl]ether) (0.26 g, 0.5 mmol), aniline (0.23 g, 2.4 mmol), and toluene/water mixture. The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.76 g of yellow solid was obtained. Yield: 61%. 1H NMR (CDCl3, 400 MHz): δ 8.39 (t, J=8.1 Hz, 1H), 7.72 (d, J=6.5 Hz, 1H), 7.62 (d, J=7.9 Hz, 1H), 7.39-7.30 (m, 3H), 7.17 (d, J=8.5 Hz, 2H), 7.00-6.96 (m, 3H), 6.88 (d, J=8.1 Hz, 1H), 3.92 (s, 3H), 2.00-1.94 (m, 4H), 1.09-1.03 (m, 4H), 0.67-0.58 (m, 10H).
Example 16—Preparation of Precursor 285
Figure US10008681-20180626-C00035
To a dry, nitrogen-flushed flask was charged with Precursor 275 (0.77 g, 1.5 mmol), potassium tert-butoxide (0.20 g, 1.8 mmol), Pd(dba)2 (0.14 g, 0.2 mmol), DPE-phos (0.16 g, 0.3 mmol), 2-iodopyridine (0.31 g, 1.5 mmol), and anhydrous toluene. The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.49 g of yellow solid was obtained. Yield: 55%. 1H NMR (CDCl3, 400 MHz): δ 8.13 (d, J=8.5 Hz, 1H), 8.10 (d, J=8.2 Hz, 1H), 7.62-7.57 (m, 2H), 7.44 (m, 1H), 7.36-7.31 (m, 3H), 7.29-7.25 (m, 2H), 7.16 (t, J=7.2 Hz, 1H), 7.00 (d, J=10.7 Hz, 1H), 6.94 (d, J=7.5 Hz, 1H), 6.81 (d, J=8.0 Hz, 1H), 6.75-6.70 (m, 2H), 3.74 (s, 3H), 1.94-1.88 (m, 4H), 1.03-0.97 (m, 4H), 0.60-0.48 (m, 10H).
Example 17—Preparation of Ligand 405
Figure US10008681-20180626-C00036
To a dry, nitrogen-flushed flask was charged with Precursor 285 (0.22 g, 0.3 mmol) and BBr3 (0.4 mL, 3.0 mmol). The mixture was stirred for 3 h. Water was added to quench the reaction. The crude mixture was extracted with dichloromethane and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.18 g of yellow solid was obtained. Yield: 85%. 1H NMR (CDCl3, 400 MHz): δ 8.87 (s, 1H), 8.12 (s, 1H), 7.82 (t, J=8.5 Hz, 1H), 7.66 (d, J=7.9 Hz, 1H), 7.56 (d, J=7.6 Hz, 1H), 7.44 (t, J=6.8 Hz, 1H), 7.37-7.15 (m, 5H), 7.03 (t, J=8.5 Hz, 2H), 6.89 (d, J=7.4 Hz, 1H), 7.78-7.72 (m, 3H), 1.98-1.89 (m, 4H), 1.08-1.01 (m, 4H), 0.66-0.58 (m, 10H).
Example 18—Preparation of Precursor 266
Figure US10008681-20180626-C00037
To a dry, nitrogen-flushed flask was charged with Precursor 253 (1.21 g, 5.6 mmol), Precursor 246 (1.42 g, 5.6 mmol), potassium tert-butoxide (0.75 g, 6.6 mmol), anhydrous THF. The mixture was stirred for 12 h. Excess ammonium acetate, acidic acid was added. The mixture was refluxed for 2 h. After cooling to room temperature, the crude mixture of the intermediate was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1).
To a dry, nitrogen-flushed flask was charged with the intermediate above (0.67 g, 1.6 mmol), potassium tert-butoxide (0.41 g, 3.6 mmol), 1-iodobutane (0.41 mL, 3.6 mmol), and anhydrous THF (20 mL). The mixture was stirred for 24 h. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.80 g of yellow solid was obtained. Yield: 72%. 1H NMR (CDCl3, 400 MHz): δ 8.29 (s, 1H), 8.06 (s, 1H), 7.63 (q, J=6.8 Hz, 2H), 7.53 (s, 1H), 7.39 (t, J=7.8 Hz, 1H), 7.00 (d, J=7.4 Hz, 1H), 6.92 (d, J=8.1 Hz, 1H), 4.10 (s, 3H), 2.00-1.97 (m, 4H), 1.40 (s, 9H), 1.09-1.03 (m, 4H), 0.66-0.57 (m, 10H).
Example 19—Preparation of Precursor 276
Figure US10008681-20180626-C00038
To a dry, nitrogen-flushed flask was charged with Precursor 266 (0.80 g, 1.5 mmol), potassium tert-butoxide (0.21 g, 1.8 mmol), Pd(dba)2 (0.14 g, 0.2 mmol), DPE-phos(bis[2-(diphenylphosphino)phenyl]ether) (0.17 g, 0.3 mmol), aniline (0.16 g, 1.5 mmol), and anhydrous toluene (20 mL). The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.66 g of yellow solid was obtained. Yield: 81%. 1H NMR (CDCl3, 400 MHz): δ 7.91 (s, 1H), 7.74 (s, 1H), 7.59 (s, 2H), 7.36 (t, J=7.9 Hz, 1H), 7.29-7.27 (m, 2H), 7.13 (t, J=8.6 Hz, 3H), 6.98 (d, J=7.5 Hz, 1H), 6.92-6.90 (m, 2H), 4.06 (s, 3H), 1.99-1.94 (m, 4H), 1.40 (s, 9H), 1.09-1.04 (m, 4H), 0.67-0.62 (m, 10H).
Example 20—Preparation of Precursor 286
Figure US10008681-20180626-C00039
To a dry, nitrogen-flushed flask was charged with Precursor 276 (0.65 g, 1.2 mmol), potassium tert-butoxide (0.17 g, 1.5 mmol), Pd(dba)2 (0.11 g, 0.1 mmol), DPE-phos (0.13 g, 0.2 mmol), 2-iodopyridine (0.30 g, 1.2 mmol), and anhydrous toluene (20 mL). The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.65 g of yellow solid was obtained. Yield: 86%. 1H NMR (CDCl3, 400 MHz): δ 8.24 (d, J=4.5 Hz, 1H), 8.13 (s, 1H), 7.73 (s, 1H), 7.58 (d, J=7.9 Hz, 1H), 7.52 (d, J=7.9 Hz, 1H), 7.44 (t, J=7.0 Hz, 1H), 7.36 (t, J=7.8 Hz, 1H), 7.30 (t, J=8.3 Hz, 2H), 7.25-7.22 (m, 3H), 7.10 (t, J=7.2 Hz, 1H), 6.97 (d, J=7.8 Hz, 1H), 6.88 (d, J=8.1 Hz, 1H), 6.81-6.75 (m, 2H), 3.99 (s, 3H), 1.98-1.93 (m, 4H), 1.36 (s, 9H), 1.07-1.02 (m, 4H), 0.65-0.55 (m, 10H).
Example 21—Preparation of Ligand 406
Figure US10008681-20180626-C00040
To a dry, nitrogen-flushed flask was charged with Precursor 286 (0.65 g, 1.1 mmol) and pyridine hydrochloride (5 g). The mixture was refluxed for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.59 g of yellow solid was obtained. Yield: 94%. 1H NMR (CDCl3, 400 MHz): δ 9.19 (s, 1H), 8.14 (s, 1H), 7.78 (s, 1H), 7.61 (d, J=7.8 Hz, 1H), 7.53 (s, 1H), 7.47-7.42 (m, 2H), 7.30-7.24 (m, 4H), 7.24-7.16 (m, 2H), 7.11-7.09 (m, 1H), 6.87 (d, J=8.0 Hz, 1H), 6.75 (d, J=7.9 Hz, 3H), 1.94-1.89 (m, 4H), 1.29 (s, 9H), 1.06-1.01 (m, 4H), 0.65-0.59 (m, 10H).
Example 22—Preparation of Precursor 267
Figure US10008681-20180626-C00041
To a dry, nitrogen-flushed flask was charged with Precursor 253 (1.97 g, 9.0 mmol), Precursor 247 (2.04 g, 9.0 mmol), potassium tert-butoxide (1.22 g, 10.9 mmol), anhydrous THF (40 mL). The mixture was stirred for 12 h. Excess ammonium acetate, acidic acid was added. The mixture was refluxed for 2 h. After cooling to room temperature, the crude mixture of the first intermediate was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1).
To a dry, nitrogen-flushed flask was charged the first intermediate (0.53 g, 1.4 mmol), potassium tert-butoxide (0.35 g, 3.1 mmol), 1-iodobutane (0.35 mL, 3.1 mmol), and anhydrous THF (20 mL). The mixture was stirred for 24 h. The crude mixture of the second intermediate was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1).
To a dry, nitrogen-flushed flask was charged with the second intermediate (0.64 g, 1.3 mmol), 4,5-dichloro-3,6-dioxocyclohexa-1,4-diene-1,2-dicarbonitrile(DDQ) (0.42 g, 1.8 mmol), and anhydrous 1,4-dioxane (40 mL). The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with saturated sodium dicarbonate solution, dichloromethane and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.61 g of yellow solid was obtained. Yield: 79.5%. 1H NMR (CDCl3, 400 MHz): δ 9.62 (s, 1H), 8.00 (s, 1H), 7.77-7.75 (m, 4H), 7.48 (t, J=7.9 Hz, 1H), 7.06 (d, J=7.5 Hz, 1H), 6.99 (d, J=8.1 Hz, 1H), 4.23 (s, 3H), 2.17-2.00 (m, 4H), 1.08-1.03 (m, 4H), 0.67-0.57 (m, 10H).
Example 23—Preparation of Precursor 277
Figure US10008681-20180626-C00042
To a dry, nitrogen-flushed flask was charged with Precursor 267 (0.61 g, 1.2 mmol), potassium tert-butoxide (0.17 g, 1.5 mmol), Pd(dba)2 (0.11 g, 0.1 mmol), DPE-phos(bis[2-(diphenylphosphino)phenyl]ether) (0.13 g, 0.2 mmol), aniline (0.13 g, 1.2 mmol), and anhydrous toluene (20 mL). The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.51 g of yellow solid was obtained. Yield: 83%. 1H NMR (CDCl3, 300 MHz): δ 9.15 (s, 1H), 7.96 (s, 1H), 7.80 (d, J=8.5 Hz, 1H), 7.70 (d, J=8.7 Hz, 1H), 7.55 (d, J=8.7 Hz, 1H), 7.46-7.30 (m, 6H), 7.04 (d, J=7.5 Hz, 2H), 6.95 (d, J=8.2, 1H), 6.09 (s, 1H), 4.09 (s, 3H), 2.08-2.04 (m, 4H), 1.07-1.02 (m, 4H), 0.65-0.58 (m, 10H).
Example 24—Preparation of Precursor 287
Figure US10008681-20180626-C00043
To a dry, nitrogen-flushed flask was charged with Precursor 277 (0.51 g, 1.0 mmol), potassium tert-butoxide (0.14 g, 1.2 mmol), Pd(dba)2 (0.09 g, 0.1 mmol), DPE-phos (0.11 g, 0.2 mmol), 2-iodopyridine (0.23 g, 1.0 mmol), and anhydrous toluene (20 mL). The mixture was refluxed for 24 h. After cooling to room temperature, ethyl acetate was added, and the mixture was stirred for five minutes. The crude mixture was extracted with ethyl acetate and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.52 g of yellow solid was obtained. Yield: 89%. 1H NMR (CDCl3, 400 MHz): δ 9.24 (s, 1H), 8.30 (s, 1H), 7.95 (s, 1H), 7.85 (d, J=8.5 Hz, 1H), 7.74 (d, J=8.7 Hz, 1H), 7.54 (d, J=8.6 Hz, 1H), 7.51 (t, J=8.3 Hz, 2H), 7.42-7.31 (m, 5H), 7.17 (m, 1H), 7.01 (d, J=7.5 Hz, 1H), 6.91 (t, J=8.3 Hz, 2H), 6.85 (t, J=8.0 Hz, 1H), 3.89 (s, 3H), 2.09-2.04 (m, 4H), 1.08-1.00 (m, 4H), 0.65-0.54 (m, 10H).
Example 25—Preparation of Ligand 407
Figure US10008681-20180626-C00044
To a dry, nitrogen-flushed flask was charged with Precursor 287 (0.52 g, 0.9 mmol) and pyridine hydrochloride (5 g). The mixture was refluxed for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on silica gel with mixture of hexane and ethyl acetate (v/v=10:1). 0.48 g of yellow solid was obtained. Yield: 95%. 1H NMR (CDCl3, 400 MHz): δ 9.39 (s, 1H), 8.90 (s, 1H), 8.30 (s, 1H), 7.99 (s, 1H), 7.88 (d, J=8.5 Hz, 1H), 7.77 (d, J=8.7 Hz, 1H), 7.67 (d, J=8.6 Hz, 1H), 7.57 (d, J=8.5 Hz, 1H), 7.51 (t, J=7.0 Hz, 1H), 7.42-7.30 (m, 5H), 7.23 (s, 1H), 6.94-6.85 (m, 4H), 2.08-2.01 (m, 4H), 1.12-1.06 (m, 4H), 0.71-0.64 (m, 10H).
Example 26—Preparation of Precursor 228
Figure US10008681-20180626-C00045
A mixture of 2-acetylcarbazole, copper powder and potassium carbonate was degassed by three pump-fill cycles. To the solid mixture was added 50 mL DMF and 2-iodopyridine. The mixture was heated to 130° C. overnight. After cooling down to room temperature, dichloromethane was added to the mixture and filtered through celite. The organic solvent was extracted with water and dried with magnesium sulfate. The crude 1-(9-(pyridin-2-yl)carbazol-2-yl)ethanone was then purified by column chromatography using dichloromethane as eluent. The product was obtained as an off-white solid.
To a mixture of 1-(9-(pyridin-2-yl)carbazol-2-yl)ethanone and iodide was added 10 mL pyridine. The mixture was heated at 90° C. overnight. The solution was cooled down to room temperature and the volatiles were removed under vacuum. The solid was filtered and washed with cold acetone. The product was obtained as a yellow solid. Yield: 1.12 g (2.28 mmol, 65%). 1H NMR (d6-DMSO, 300 MHz): δ 9.01 (d, J=5.6 Hz, 2H), 8.80-8.72 (m, 2H), 8.55 (d, J=8.2 Hz, 1H), 8.48 (s, 1H), 8.43 (d, J=7.7 Hz, 1H), 8.29 (t, J=7.1 Hz, 2H), 8.20 (t, J=7.8 Hz, 1H), 8.06 (d, J=8.2 Hz, 1H), 7.86 (t, J=8.6 Hz, 2H), 7.65-7.47 (m, 2H), 7.42 (t, J=7.5 Hz, 1H), 6.60 (s, 2H).
Example 27—Preparation of Precursor 288
Figure US10008681-20180626-C00046
To a mixture of Precursor 218 (0.80 g, 2.28 mmol) and Precursor 228 (1.12 g, 2.28 mmol) was added 30 g ammonium acetate and 20 mL methanol. The mixture was refluxed overnight. The reaction mixture was partitioned with dichloromethane and water. The organics was dried with magnesium sulfate and evaporated under vacuum. The crude product was purified with column chromatography using dichloromethane as eluent. The product was obtained as a yellow solid. Yield: 0.75 g (1.22 mmol, 53%). 1H NMR (CDCl3, 400 MHz): δ8.76-8.75 (m, 1H), 8.63 (s, 1H), 8.23 (d, J=8.2 Hz, 1H), 8.18-8.13 (m, 2H), 8.06-8.02 (m, 2H), 7.95-7.93 (m, 2H), 7.90 (d, J=8.2 Hz, 1H), 7.74 (d, J=8.1 Hz), 7.57-7.56 (m, 3H), 7.47 (t, J=7.7 Hz, 1H), 7.41 (t, J=7.8 Hz, 1H), 7.36-7.32 (m, 2H), 7.14 (t, J=7.1 Hz, 1H), 7.06 (d, J=8.0 Hz, 1H), 3.91 (s, 2H), 1.42 (s, 18H).
Example 28—Preparation of Ligand 408
Figure US10008681-20180626-C00047
A mixture of Precursor 288 (0.75 g, 1.22 mmol) and 20 g pyridinum hydrochloride was heated to around 200° C. under nitrogen atmosphere. The reaction progress was monitored by TLC. When all the starting material was consumed, the reaction was quenched with water when hot. The solution was then partitioned with dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product was purified by column chromatography using dichloromethane as eluent. The product was obtained as a yellow solid. Yield: 0.54 g (0.90 mmol, 74%). 1H NMR (CDCl3, 500 MHz): δ 14.82 (s, 1H), 8.69 (dd, J=4.9 Hz, 1.3 Hz, 1H), 8.43 (s, 1H), 8.18 (d, J=8.1 Hz, 1H), 8.10 (d, J=7.7 Hz, 1H), 7.95-7.90 (m, 3H), 7.88 (dd, J=8.0 Hz, 1.4 Hz, 1H), 7.84-7.82 (m, 2H), 7.69 (d, J=8.1 Hz, 1H), 7.52 (s, 1H), 7.47 (s, 2H), 7.42 (t, J=7.7 Hz, 1H), 7.30-7.25 (m, 3H), 7.02 (dd, J=8.2 Hz, 1.0 Hz, 1H), 6.89 (t, J=7.5 Hz, 1H), 1.36 (s, 18H).
Example 29—Preparation of Precursor 289
Figure US10008681-20180626-C00048
To a degassed 250 mL round-bottom Schlenk flask was added Precursor 248 (1.48 g, 5.16 mmol), potassium tert-butoxide (0.69 g, 6.19 mmol) and 50 mL anhydrous THF. The mixture was stirred at room temperature for 2 hours under nitrogen atmosphere. A solution of Precursor 253 (1.12 g, 5.16 mmol) in 50 mL THF was then added to the above mixture through a cannula. The reaction mixture was stirred overnight at room temperature under nitrogen. To the mixture was then added 50 g ammonium acetate and 25 mL glacial acetic acid. The volatile organics was then removed by distillation at about 100° C. The crude product was then partitioned between dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product of 9-methoxy-2-(9-(pyridin-2-yl)-9H-carbazol-2-yl)-5H-indeno[1,2-b]pyridine was purified by column chromatography using dichloromethane as eluent.
To a degassed round bottom flask with 9-methoxy-2-(9-(pyridin-2-yl)-9H-carbazol-2-yl)-5H-indeno[1,2-b]pyridine (0.45 g, 1.02 mmol), potassium tert-butoxide (0.27 g, 2.45 mmol) dissolved in 50 mL anhydrous THF was added 1-bromohexane (0.50 g, 3.05 mmol). The resulting solution was refluxed for 2 hours and then cooled down to room temperature. The crude product was then partitioned between dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product was purified by column chromatography using dichloromethane as eluent. The product was obtained as yellow oil. Yield: 0.59 g (0.97 mmol, 95%). 1H NMR (CDCl3, 400 MHz): δ8.81-8.78 (m, 2H), 8.20 (d, J=8.2 Hz, 1H), 8.14 (d, J=9.5 Hz, 2H), 8.00 (t, J=7.7 Hz, 1H), 7.88 (d, J=8.2 Hz, 1H), 7.83-7.7.78 (m, 2H), 7.65 (d, J=8.0 Hz, 1H), 7.45 (t, J=7.7 Hz, 1H), 7.40-7.31 (m, 3H), 7.00 (d, J=7.4 Hz, 1H), 6.91 (d, J=8.1 Hz, 1H), 4.06 (s, 3H), 2.01-1.94 (m, 4H), 1.11-0.99 (m, 12H), 0.74 (t, J=7.1 Hz, 6H), 0.64-0.60 (m, 4H).
Example 30—Preparation of Ligand 409
Figure US10008681-20180626-C00049
A degassed 100 mL round bottom flask charged with Precursor 289 (0.59 g, 0.97 mmol) and 20 g pyridinum hydrochloride was heated to around 200° C. The reaction was monitored by TLC. When all the starting material was consumed, the reaction was quenched with water when hot. The solution was then partitioned between dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product was purified by column chromatography using dichloromethane as eluent. The product was obtained as yellow oil. Yield: 0.47 g (0.79 mmol, 82%). 1H NMR (CDCl3, 500 MHz): δ 9.47 (s, 1H), 8.80 (d, J=4.9 Hz, 1H), 8.60 (s, 1H), 8.21 (d, J=8.1 Hz, 1H), 8.16 (d, J=7.7 Hz, 1H), 8.02-7.98 (m, 2H), 7.88 (d, J=8.3 Hz, 1H), 7.75 (d, J=8.1 Hz, 1H), 7.71-7.67 (m, 2H), 7.48 (t, J=7.7 Hz, 1H), 7.37-7.30 (m, 3H), 6.92-6.89 (m, 2H), 2.02-1.92 (m, 4H), 1.17-1.03 (m, 12H), 0.79-0.71 (m, 10H). 13C NMR (CDCl3, 126 MHz): δ 161.20, 155.55, 154.47, 152.51, 151.76, 149.81, 141.75, 140.39, 140.11, 138.64, 137.09, 130.96, 130.84, 126.60, 124.95, 124.42, 124.03, 121.49, 121.15, 120.49, 120.40, 119.88, 119.15, 117.90, 114.24, 113.45, 111.30, 109.64, 54.30, 39.72, 31.49, 29.68, 24.04, 22.55, 13.98.
Example 31—Preparation of Complex 101
Figure US10008681-20180626-C00050
To a round bottom flask was charged with Ligand 401 (0.42 g, 0.69 mmol), K2PtCl4 (0.35 g, 0.83 mmol), and mixture of glacial acetic acid (140 mL) and chloroform (5 mL). The mixture was refluxed under argon for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on alumina with mixture of hexane and ethyl acetate (v/v=10:1). 0.5 g of orange solid was obtained. Yield: 90%. 1H NMR (CD2Cl2, 500 MHz): δ 10.18 (d, J=6.3 Hz, 1H), 8.23 (s, 1H), 7.99 (d, J=8.4 Hz, 1H), 7.90 (s, 1H), 7.72-7.69 (m, 2H), 7.64-7.59 (m, 4H), 7.54-7.51 (m, 2H), 7.49-7.34 (m, 3H), 7.25 (d, J=8.4 Hz, 1H), 6.98 (t, J=7.9 Hz, 1H), 6.85 (t, J=6.6 Hz, 1H), 6.72 (t, J=7.5 Hz, 1H), 6.41 (d, J=8.7 Hz, 1H), 6.14 (d, J=8.3 Hz, 1H), 1.43 (s, 18H). MS(FAB): 797.3 (M+)
Example 32—Preparation of Complex 102
Figure US10008681-20180626-C00051
To a round bottom flask were charged with Ligand 402 (0.09 g, 0.13 mmol), K2PtCl4 (0.07 g, 0.16 mmol), and mixture of glacial acetic acid (24 mL) and chloroform (0.9 mL). The mixture was refluxed under nitrogen for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on alumina with mixture of hexane and ethyl acetate (v/v=10:1). 0.10 g of yellow solid was obtained. Yield: 91%. 1H NMR (CD2Cl2, 300 MHz): δ 11.05 (s, 1H), 8.16 (s, 1H), 7.98-7.93 (m, 2H), 7.83 (s, 1H), 7.67 (t, J=7.2 Hz, 2H), 7.56-7.54 (m, 4H), 7.50 (t, J=7.4 Hz, 1H), 7.40-7.32 (m, 3H), 7.30-7.25 (m, 4H), 6.90 (t, J=7.9 Hz, 1H), 6.67 (t, J=7.2 Hz, 1H), 6.55 (s, 1H), 6.06 (d, J=8.3 Hz, 1H), 1.36-1.32 (m, 18H). MS(ESI): 847.6 (M+).
Example 33—Preparation of Complex 103
Figure US10008681-20180626-C00052
To a round bottom flask was charged with Ligand 403 (0.34 g, 0.63 mmol), K2PtCl4 (0.31 g, 0.76 mmol), and mixture of glacial acetic acid (100 mL) and chloroform (5 mL). The mixture was refluxed under argon for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on alumina with mixture of hexane and ethyl acetate (v/v=10:1). 0.42 g of yellow solid was obtained. Yield: 90%. 1H NMR (CD2Cl2, 500 MHz): δ 10.28 (d, J=6.1 Hz, 1H), 7.86 (d, J=7.6 Hz, 1H), 7.71 (t, J=7.5 Hz, 2H), 7.61 (t, J=8.7 Hz, 2H), 7.52 (t, J=7.0 Hz, 1H), 7.44-7.47 (m, 2H), 7.38 (d, J=7.2 Hz, 2H), 7.05 (d, J=8.3 Hz, 1H), 6.98 (t, J=8.2 Hz, 1H), 6.86 (t, J=6.8 Hz, 1H), 6.68 (d, J=7.1 Hz, 1H), 6.42 (d, J=8.1 Hz, 1H), 6.12 (d, J=8.3 Hz, 1H), 1.92-1.97 (m, 4H), 1.06-1.10 (m, 4H), 0.66-0.71 (m, 10H).
Example 34—Preparation of Complex 104
Figure US10008681-20180626-C00053
To a round bottom flask were charged with Ligand 404 (0.04 g, 0.06 mmol), K2PtCl4 (0.03 g, 0.08 mmol), and mixture of glacial acetic acid (13 mL) and chloroform (0.5 mL). The mixture was refluxed under nitrogen for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on alumina with mixture of hexane and ethyl acetate (v/v=10:1). 0.05 g of yellow solid was obtained. Yield: 95%. 1H NMR (CDCl3, 300 MHz): δ 11.16 (s, 1H), 7.98 (d, J=8.2 Hz, 1H), 7.79 (d, J=7.7 Hz, 1H), 7.66 (t, J=7.2 Hz, 2H), 7.58-7.45 (m, 3H), 7.42 (t, J=7.2 Hz, 1H), 7.35 (t, J=8.4 Hz, 3H), 7.27 (q, J=7.2 Hz, 2H), 7.09 (d, J=8.3 Hz, 1H), 6.89 (t, J=7.9 Hz, 1H), 6.63 (d, J=6.9 Hz, 1H), 6.57 (s, 1H), 6.05 (d, J=8.0 Hz, 1H) 2.01-1.95 (m, 4H), 1.12-1.03 (m, 4H), 0.71-0.61 (m, 10H). MS (ESI): 782.5 (M+).
Example 35—Preparation of Complex 105
Figure US10008681-20180626-C00054
To a round bottom flask was charged with Ligand 405 (0.09 g, 0.2 mmol), K2PtCl4 (0.08 g, 0.2 mmol), and mixture of glacial acetic acid (30 mL) and chloroform (1.2 mL). The mixture was refluxed under nitrogen for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on alumina with mixture of hexane and ethyl acetate (v/v=10:1). 0.1 g of yellow solid was obtained. Yield: 90%. 1H NMR (CD2Cl2, 400 MHz): δ 9.92 (d, J=6.2 Hz, 1H), 7.87-7.87 (m, 2H), 7.57 (t, J=7.9 Hz, 1H), 7.46-7.25 (m, 7H), 7.03 (d, J=8.2 Hz, 1H), 6.99 (t, J=7.9 Hz, 1H), 6.67 (d, J=7.0 Hz, 1H), 6.55 (t, J=8.5 Hz, 1H), 2.06-1.98 (m, 4H), 1.11-1.04 (m, 4H), 0.71-0.63 (m, 10H). MS(ESI): 769.3 (M+).
Example 36—Preparation of Complex 106
Figure US10008681-20180626-C00055
To a round bottom flask were charged with Ligand 406 (0.59 g, 1.0 mmol), K2PtCl4 (0.50 g, 1.2 mmol), and mixture of glacial acetic acid (180 mL) and chloroform (6.5 mL). The mixture was refluxed under nitrogen for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on alumina with mixture of hexane and ethyl acetate (v/v=10:1). 0.75 g of yellow solid was obtained. Yield: 95%. 1H NMR (CD2Cl2, 500 MHz): δ 10.25 (d, J=5.8 Hz, 1H), 7.85 (d, J=7.7 Hz, 1H), 7.72 (t, J=6.9 Hz, 2H), 7.63-7.60 (m, 2H), 7.52 (t, J=7.9 Hz, 1H), 7.49 (s, 1H), 7.45 (t, J=7.7 Hz, 1H), 7.39 (d, J=7.2 Hz, 1H), 7.04 (d, J=8.1 Hz, 1H), 6.84 (t, J=6.5 Hz, 1H), 6.67 (d, J=6.9 Hz, 1H), 6.46 (d, J=8.9 Hz, 1H), 6.17 (s, 1H), 2.10-1.98 (m, 4H), 1.14-1.09 (m, 13H), 0.80-0.68 (m, 10H). MS(ESI): 788.9 (M+).
Example 37—Preparation of Complex 107
Figure US10008681-20180626-C00056
To a round bottom flask were charged with Ligand 407 (0.25 g, 0.4 mmol), K2PtCl4 (0.22 g, 0.5 mmol), and mixture of glacial acetic acid (80 mL) and chloroform (3 mL). The mixture was refluxed under nitrogen for 24 h. After cooling to room temperature, the crude mixture was extracted with dichloromethane and purified by chromatography on alumina with mixture of hexane and ethyl acetate (v/v=10:1). 0.32 g of yellow solid was obtained. Yield: 96%. 1H NMR (CD2Cl2, 500 MHz): δ10.32 (d, J=6.0 Hz, 1H), 8.26 (s, 1H), 7.77-7.72 (m, 4H), 7.66 (t, J=7.6 Hz, 1H), 7.64-7.51 (m, 3H), 7.45 (d, J=8.1 Hz, 2H), 7.16 (d, J=8.4 Hz, 1H), 6.88 (t, J=6.9 Hz, 1H), 6.76 (d, J=7.1 Hz, 1H), 6.56-6.51 (m, 2H), 2.23-2.09 (m, 4H), 1.18-1.11 (m, 4H), 0.89-0.66 (m, 10H). MS(ESI): 756.8 (M+).
Example 38—Preparation of Complex 108
Figure US10008681-20180626-C00057
A mixture of Ligand 408 (0.54 g, 0.90 mmol), potassium tetrachloroplatinate (0.45 g, 1.08 mmol) in 50 mL glacial acetic acid and 10 mL chloroform was refluxed for 2 days. The solution was cooled down to room temperature and was partitioned between dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product was purified by column chromatography using dichloromethane as eluent. The product was obtained as an orange solid. Yield: 0.44 g (62%). 1H NMR (CDCl3, 500 MHz): δ9.97 (dd, J=6.0 Hz, 1.3 Hz, 1H), 8.07 (s, 1H), 7.97-7.94 (m, 2H), 7.90 (d, J=8.4 Hz, 1H), 7.87 (d, J=7.4 Hz, 1H), 7.76 (t, J=7.8 Hz, 1H), 7.64 (s, 1H), 7.59 (s, 2H), 7.51 (s, 1H), 7.45 (d, J=8.0 Hz, 1H), 7.39 (t, J=7.4 Hz, 1H), 7.36-7.31 (m, 2H), 7.26 (t, J=7.4 Hz, 1H), 7.20 (dd, J=8.3 Hz, 1.1 Hz, 1H), 6.83 (t, J=6.2 Hz, 1H), 6.74 (t, J=7.4 Hz, 1H), 1.49 (s, 18H). 13C NMR (CDCl3, 126 MHz): δ 164.76, 164.27, 153.13, 151.87, 150.21, 149.45, 149.39, 147.04, 142.74, 139.64, 138.29, 137.41, 136.85, 131.07, 130.09, 128.50, 126.17, 124.64, 124.23, 123.56, 122.78, 122.09, 121.47, 121.45, 118.75, 118.24, 117.58, 115.14, 114.55, 114.15, 113.62, 113.47, 35.18, 31.63
Example 39—Preparation of Complex 109
Figure US10008681-20180626-C00058
A mixture of Ligand 409 (0.47 g, 0.79 mmol), potassium tetrachloroplatinate (0.39 g, 0.95 mmol) in 50 mL glacial acetic acid and 10 mL chloroform was refluxed for 2 days. The solution was cooled down to room temperature and was partitioned between dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product was purified by column chromatography using dichloromethane as eluent. The product was obtained as an orange solid. Yield: 0.32 g (51%). 1H NMR (CD2Cl2, 500 MHz): δ 10.31 (d, J=6.0 Hz, 1H), 8.18 (d, J=8.6 Hz, 1H), 8.08 (d, J=7.5 Hz, 1H), 8.03 (d, J=8.3 Hz, 1H), 8.01-8.97 (m, 1H), 7.84 (d, J=7.6 Hz, 1H), 7.70 (d, J=7.9 Hz, 1H), 7.61 (d, J=8.0 Hz, 1H), 7.53 (d, J=7.6 Hz, 1H), 7.50-7.46 (m, 2H), 7.39 (t, J=7.4 Hz, 1H), 7.18-7.15 (m, 1H), 7.08 (d, J=8.3 Hz, 1H), 6.71 (d, J=6.7 Hz, 1H), 2.11-1.99 (m, 4H), 1.16-1.05 (m, 12H), 0.83-0.75 (m, 10H). 13C NMR (CD2Cl2, 126 MHz): δ 161.73, 160.24, 154.76, 153.50, 150.23, 147.53, 142.79, 142.19, 139.79, 138.15, 137.63, 132.43, 129.54, 128.37, 126.47, 126.04, 123.09, 122.79, 121.53, 121.10, 118.78, 118.36, 118.13, 115.80, 114.18, 114.12, 113.11, 108.18, 55.38, 39.91, 31.50, 29.68, 24.03, 22.53, 13.71.
Example 40—Preparation of Complex 110
Figure US10008681-20180626-C00059
A mixture of Ligand 410 (0.12 g, 0.18 mmol), potassium tetrachloroplatinate (0.08 g, 0.20 mmol) in 50 mL glacial acetic acid and 10 mL chloroform was refluxed for 2 days. The solution was cooled down to room temperature and was partitioned between dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product was purified by column chromatography using dichloromethane as eluent.
The product was obtained as an orange-red solid. Yield: 0.11 g (72%). 1H NMR (CD2Cl2, 500 MHz): δ 10.06 (dd, J=6.1 Hz, 1.5 Hz, 1H), 8.11 (s, 1H), 8.05 (d, J=8.7 Hz, 1H), 8.00-7.97 (m, 2H), 7.91-7.88 (m, 2H), 7.67 (s, 1H), 7.65 (s, 3H), 7.61 (d, J=8.0 Hz, 1H), 7.53-7.50 (m, 2H), 7.33 (t, J=7.5 Hz, 1H), 7.19 (d, J=8.4 Hz, 1H), 6.97 (t, J=6.6 Hz, 1H), 6.72 (t, J=7.5 Hz, 1H), 1.47 (s, 18H), 1.43 (s, 9H). 13C NMR (CD2Cl2, 126 MHz): δ 165.49, 164.82, 153.62, 152.55, 150.96, 149.74, 147.84, 146.84, 143.06, 138.76, 138.41, 138.29, 137.62,* 131.68, 130.70, 128.69, 125.04, 124.92, 124.84, 124.31, 123.77, 122.42, 122.05, 119.42, 118.76, 118.47, 118.14, 115.81, 115.07, 114.38, 114.14, 114.09, 35.63. 35.19. 31.99. 31.89.
Example 41—Preparation of Complex 129
Figure US10008681-20180626-C00060
A mixture of Ligand ONCN09 (0.038 g, 0.06 mmol), potassium tetrachloroplatinate (0.03 g, 0.07 mmol) in 10.4 mL glacial acetic acid and 0.4 mL chloroform was refluxed for 12 hours. The solution was cooled down to room temperature and was partitioned between dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product was purified by column chromatography using hexane and ethyl acetate (v/v=10:1) as eluent. The product was obtained as an orange solid. Yield: 0.046 g (94%). 1H NMR (600 MHz, CD2Cl2) δ 10.36 (d, J=6.2 Hz, 1H), 8.47 (s, 1H), 8.30 (d, J=8.4 Hz, 1H), 7.77 (d, J=7.9 Hz, 2H), 7.73 (d, J=11.9 Hz, 1H), 7.66 (s, 2H), 7.59 (d, J=8.8 Hz, 1H), 7.54 (t, J=5.3 Hz, 3H), 7.47 (d, J=7.3 Hz, 2H), 7.42 (s, 2H), 6.92 (t, J=6.5 Hz, 1H), 6.79 (d, J=8.2 Hz, 1H), 6.59 (d, J=8.8 Hz, 1H), 6.56 (d, J=8.9 Hz, 1H), 1.44 (s, 18H).
Example 42—Preparation of Complex 130
Figure US10008681-20180626-C00061
A mixture of Ligand ONCN12 (0.044 g, 0.07 mmol), potassium tetrachloroplatinate (0.03 g, 0.08 mmol) in 12.5 mL glacial acetic acid and 0.4 mL chloroform was refluxed for 12 hours. The solution was cooled down to room temperature and was partitioned between dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product was purified by column chromatography using hexane and ethyl acetate (v/v=10:1) as eluent. The product was obtained as an orange solid. Yield: 0.054 g (95%). 1H NMR (600 MHz, CD2Cl2) δ 10.40 (d, J=4.9 Hz, 1H), 8.76 (s, 1H), 8.21 (d, J=8.6 Hz, 2H), 7.88 (d, J=7.6 Hz, 1H), 7.84 (d, J=8.6 Hz, 2H), 7.62 (d, J=7.6 Hz, 1H), 7.54 (d, J=7.8 Hz, 2H), 7.49 (s, 1H), 7.47-7.39 (m, 3H), 7.35-7.27 (m, 1H), 7.10 (d, J=8.2 Hz, 1H), 6.87 (t, J=6.6 Hz, 1H), 6.72 (d, J=7.1 Hz, 2H), 6.02 (d, J=8.9 Hz, 1H), 5.71 (d, J=8.2 Hz, 1H), 2.07 (m, 4H), 1.15 (m, 5H), 0.72 (m, 10H).
Example 43—Preparation of Complex 13
Figure US10008681-20180626-C00062
A mixture of Ligand ONCN14 (0.086 g, 0.14 mmol), potassium tetrachloroplatinate (0.03 g, 0.16 mmol) in 25.5 mL glacial acetic acid and 1 mL chloroform was refluxed for 12 hours. The solution was cooled down to room temperature and was partitioned between dichloromethane and water. The organic layer was dried with magnesium sulfate and the volatiles were removed under vacuum. The crude product was purified by column chromatography using hexane and ethyl acetate (v/v=10:1) as eluent. The product was obtained as an orange solid. Yield: 0.107 g (93%). 1H NMR (600 MHz, CD2Cl2) δ 10.10 (d, J=6.6 Hz, 1H), 7.86 (d, J=7.6 Hz, 1H), 7.72 (t, J=7.8 Hz, 2H), 7.65-7.54 (m, 2H), 7.46 (t, J=7.6 Hz, 2H), 7.41-7.35 (m, 2H), 7.04 (d, J=8.2 Hz, 1H), 7.01-6.95 (m, 1H), 6.90 (d, J=6.7 Hz, 1H), 6.68 (d, J=7.1 Hz, 1H), 6.35 (s, 1H), 6.15 (d, J=8.2 Hz, 1H), 2.04 (m, 4H), 1.27 (m, 3H), 1.19-1.04 (m, 10H), 0.82-0.63 (m, 9H).
Example 44—Photophysical Properties for Complexes 101, 102, 103, 105, 106, 107, 108, 109 and 129
Absorption
λmax/nm (molar extinction Emission (dichloromethane solution)
coefficient/104 mol−1dm3 cm−1) λmax/nm ϕ τ/μs Kq/mol−1dm3s−1
Complex 101 330 (2.16), 370 (1.13), 450 551 0.91 4.31 2 × 107
(0.27), 481 (0.21)
Complex 102 342 (1.96), 370 (0.99), 432 540, 605, 659 0.092 12.5 2 × 107
(0.21), 492 (0.14)
Complex 103 321 (1.87), 337 (1.31), 365 511, 540 0. 92 13.0 2 × 108
(1.17), 393 (0.79), 434 (0.44),
458 (0.38)
Complex 105 336 (0.85), 355 (0.97), 386 505, 530, 574 0.54 31.6 2 × 106
(0.56), 416 (0.42), 438 (0.34),
469 (0.04)
Complex 106 325 (2.30), 368 (1.44), 396 515, 552, 596 0.97 10.9 4 × 107
(1.03), 438 (0.54), 464 (0.46)
Complex 107 334 (1.99), 355 (1.40), 375 531, 573 0.44 26.5 7 × 106
(1.02), 433 (0.98), 474 (0.36)
Complex 108 264 (43213); 274 (45223); 324 540, 583, 625 0.41
(26577); 353 (18914); 369
(16897); 414 (13880); 442
(5902); 471 (4463)
Complex 109 278 (5218); 298 (47859); 334 553, 587 0.86
(40668); 355 (23675); 385
(15888); 413 (9370); 461
(4078); 488 (3516);
Complex 129 343 (2.09), 364 (1.51), 439 573 0.21 12.6 5 × 107
(0.66), 472 (0.37), 501 (0.31)
Example 45—General Procedures for Vacuum Deposition
In one embodiment, OLEDs were fabricated on glass substrates with pre-patterned ITO electrodes. The substrates were cleaned in an ultrasonic bath of detergent and deionized water, rinsed with deionized water, and then cleaned in sequential ultrasonic baths of dionized water, acetone, and isopropanol, and subsequently dried in an oven for 1 h. The substrates were then transferred into a vacuum chamber, in which functional layers were in sequence deposited by thermal evaporation at a pressure of 10−6-10−7 torr. The thickness of the deposited material was monitored in situ using an oscillating quartz thickness monitor. Finally a LiF buffer layer and Al cathode were vapor deposited onto the organic films. EL spectra, luminance, and CIE coordination were measured by a Photo Research Inc PR-655. Voltage-current characteristics were measured by using a Keithley 2400 source measurement unit. All devices were characterized at room temperature in the atmosphere without encapsulation.
Example 46—OLED 1
A device was fabricated according to Example 45 wherein four functional layers including MoO3 (5 nm), CzSiCz (40 nm), CsPO3: Complex 101 (4%, 30 nm) and DPOSi (30 nm), which were used as hole-injection layer, hole-transporting layer, emissive layer and electron-transporting layer respectively, were deposited in sequence. This device showed yellow emission with CIE coordinate of (0.42, 0.56), maximum current efficiency of 62.4 cd/A and efficiency roll-off of 11.9% at 1000 cd/m−2.
Example 47—OLED 2
A device was fabricated according to Example 45 wherein four functional layers including MoO3 (2 nm), DczSi (40 nm), CsPO1: Complex 101 (2%, 30 nm) and DPOSi (30 nm), which were used as hole-injection layer, hole-transporting layer, emissive layer and electron-transporting layer respectively, were deposited in sequence. This device showed yellow emission with CIE coordinate of (0.39, 0.59), maximum current efficiency of 77.0 cd/A and efficiency roll-off of 5.2% at 1000 cd/m−2.
Example 48—OLED 3
A device was fabricated with according to 45 wherein four functional layers including MoO3 (5 nm), CzSiCz (40 nm), CsPO3: Complex 103 (2%, 30 nm) and DPOSi (30 nm), which were used as hole-injection layer, hole-transporting layer, emissive layer and electron-transporting layer respectively, were deposited in sequence. This device showed green emission with CIE coordinate of (0.28, 0.61), maximum current efficiency of 43.6 cd/A and efficiency roll-off of 12.8% at 1000 cd/m−2.
Example 49—OLED 4
A device was fabricated according to Example 45 wherein six functional layers including MoO3 (5 nm), NPB (30 nm), TCTA (10 nm), TCTA: Complex 103 (10%, 15 nm), 1,3,5-tri(phenyl-2-benzimidazolyl)-benzene (TPBi): Complex 103 (10%, 15 nm) and TPBi (30 nm) which were used as hole-injection layer, hole-transporting layer, electron-blocking layer, emissive layer 1, emissive layer 2 and electron-transporting layer respectively, were deposited in sequence. This device showed green emission with CIE coordinate of (0.27, 0.60), maximum current efficiency of 60.0 cd/A and efficiency roll-off of 33.3% at 1000 cd/m−2.
Example 50—OLED 5
A device was fabricated according to Example 45 wherein six functional layers including MoO3 (5 nm), NPB (30 nm), TCTA (10 nm), CBP: Complex 103 (7%, 15 nm), TAZ: Complex 103 (7%, 15 nm) and TAZ (30 nm) which were used as hole-injection layer, hole-transporting layer, electron-blocking layer, emissive layer 1, emissive layer 2 and electron-transporting layer respectively, were deposited in sequence. This device showed green emission with CIE coordinate of (0.27, 0.60), maximum current efficiency of 78.0 cd/A and efficiency roll-off of 38.5% at 1000 cd/m−2.
Example 51—General Procedures for Solution Process Fabrication
In one embodiment, OLEDs were fabricated on glass substrates with pre-patterned indium tin oxide (ITO) electrodes. The substrates were cleaned in an ultrasonic bath of detergent and deionized water, rinsed with deionized water, and then cleaned in sequential ultrasonic baths of dionized water, acetone, and isopropanol, and subsequently dried in an oven for 1 h. The solution processable functional layers were deposition in sequence by spin coating. The samples were then then transferred into a vacuum chamber, in which the rest functional layers were in sequence deposited by thermal evaporation at a pressure of 10−6-10−7 torr. The thickness of the deposited material was monitored in situ using an oscillating quartz thickness monitor. Finally a LiF buffer layer and Al cathode were vapor deposited onto the organic films. EL spectra, luminance, and CIE coordination were measured by a Photo Research Inc PR-655. Voltage-current characteristics were measured by using a Keithley 2400 source measurement unit. All devices were characterized at room temperature in the atmosphere without encapsulation.
Example 52—OLED 6
A device was fabricated according to Example 51 wherein two solution processable functional layers including PEDOT: PPS and POSC1: Complex 101 (10%), which were used as hole-injection and hole-transporting layer and emissive layer respectively, were deposited by spin coated in sequenced. Afterward, a layer of TPBi (30 nm) was deposition by vacuum deposition as electron-transporting layer. This device showed yellow emission with CIE coordinate of (0.46, 0.54), maximum current efficiency of 35.0 cd/A and efficiency roll-off of 5.7% at 1000 cd/m−2.
All references, including publications, patent applications and patents, cited herein are hereby incorporated by reference to the same extent as if each reference was individually and specifically indicated to be incorporated by reference and was set forth in its entirety herein.
The terms “a” and “an” and “the” and similar referents as used in the context of describing the invention are to be construed to cover both the singular and the plural, unless otherwise indicated herein or clearly contradicted by context.
Recitation of ranges of values herein are merely intended to serve as a shorthand method of referring individually to each separate value falling within the range, unless otherwise indicated herein, and each separate value is incorporated into the specification as if it were individually recited herein. Unless otherwise stated, all exact values provided herein are representative of corresponding approximate values (e.g., all exact exemplary values provided with respect to a particular factor or measurement can be considered to also provide a corresponding approximate measurement, modified by “about,” where appropriate).
The use of any and all examples, or exemplary language (e.g., “such as”) provided herein, is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention unless otherwise indicated. No language in the specification should be construed as indicating any element is essential to the practice of the invention unless as much is explicitly stated.
The description herein of any aspect or embodiment of the invention using terms such as “comprising”, “having”, “including” or “containing” with reference to an element or elements is intended to provide support for a similar aspect or embodiment of the invention that “consists of”, “consists essentially of”, or “substantially comprises” that particular element or elements, unless otherwise stated or clearly contradicted by context (e.g., a composition described herein as comprising a particular element should be understood as also describing a composition consisting of that element, unless otherwise stated or clearly contradicted by context).
It should be understood that the examples and embodiments described herein are for illustrative purposes only and that various modifications or changes in light thereof will be suggested to persons skilled in the art and are to be included within the spirit and purview of this application.

Claims (6)

What is claimed is:
1. A light-emitting device comprising an organometallic complex having a chemical structure of Structure I:
Figure US10008681-20180626-C00063
wherein R1-R16 are independently hydrogen, halogen, hydroxyl, an unsubstituted alkyl, a substituted alkyl, cycloalkyl, an unsubstituted aryl, a substituted aryl, acyl, alkoxy, acyloxy, amino, nitro, acylamino, aralkyl, cyano, carboxyl, thio, styryl, aminocarbonyl, carbamoyl, aryloxycarbonyl, phenoxycarbonyl, or an alkoxycarbonyl group;
wherein each pair of adjacent R groups of R1-R16 can be independently two separate groups or one group, and form one or more 5-8 member rings with 2 to 4 X groups; and
wherein X1-X21 are independently carbon, nitrogen, silicon, germanium, or phosphorous.
2. The light-emitting device of claim 1, wherein the device is an organic light-emitting diode (OLED).
3. The light-emitting device of claim 1, wherein the efficiency roll-off at 1000 cd/m−2 is less than 7%.
4. The light-emitting device of claim 1, wherein the efficiency roll-off at 1000 cd/m−2 is less than 50%.
5. The device of claim 1, wherein the device emits green light with a CIE of (0.25±0.05, 0.63±0.05).
6. The device of claim 1, wherein the device emits yellow to orange light with a CIE of (0.40±0.1, 0.4±0.1).
US15/054,247 2012-04-12 2016-02-26 Platinum(II) complexes for OLED applications Active 2033-08-17 US10008681B2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US15/054,247 US10008681B2 (en) 2012-04-12 2016-02-26 Platinum(II) complexes for OLED applications
US15/950,650 US10243154B2 (en) 2012-04-12 2018-04-11 Platinum(II) complexes for OLED applications

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261623339P 2012-04-12 2012-04-12
US13/861,119 US9306178B2 (en) 2012-04-12 2013-04-11 Platinum(II) complexes for OLED applications
US15/054,247 US10008681B2 (en) 2012-04-12 2016-02-26 Platinum(II) complexes for OLED applications

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US13/861,119 Division US9306178B2 (en) 2012-04-12 2013-04-11 Platinum(II) complexes for OLED applications

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/950,650 Division US10243154B2 (en) 2012-04-12 2018-04-11 Platinum(II) complexes for OLED applications

Publications (2)

Publication Number Publication Date
US20160181551A1 US20160181551A1 (en) 2016-06-23
US10008681B2 true US10008681B2 (en) 2018-06-26

Family

ID=49325666

Family Applications (3)

Application Number Title Priority Date Filing Date
US13/861,119 Active 2033-12-01 US9306178B2 (en) 2012-04-12 2013-04-11 Platinum(II) complexes for OLED applications
US15/054,247 Active 2033-08-17 US10008681B2 (en) 2012-04-12 2016-02-26 Platinum(II) complexes for OLED applications
US15/950,650 Active US10243154B2 (en) 2012-04-12 2018-04-11 Platinum(II) complexes for OLED applications

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US13/861,119 Active 2033-12-01 US9306178B2 (en) 2012-04-12 2013-04-11 Platinum(II) complexes for OLED applications

Family Applications After (1)

Application Number Title Priority Date Filing Date
US15/950,650 Active US10243154B2 (en) 2012-04-12 2018-04-11 Platinum(II) complexes for OLED applications

Country Status (5)

Country Link
US (3) US9306178B2 (en)
KR (1) KR101749611B1 (en)
CN (1) CN104245714B (en)
DE (1) DE112013001975T5 (en)
WO (1) WO2013152727A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10038153B2 (en) * 2014-04-03 2018-07-31 Versitech Limited Platinum (II) emitters for OLED applications
US10144867B2 (en) 2015-02-13 2018-12-04 Universal Display Corporation Organic electroluminescent materials and devices
US10147893B2 (en) 2015-04-10 2018-12-04 Samsung Electronics Co., Ltd. Organometallic compound and organic light-emitting device including the same
EP3319959B1 (en) 2015-07-06 2021-09-01 Alkermes, Inc. Hetero-halo inhibitors of histone deacetylase
EP3319968A1 (en) 2015-07-06 2018-05-16 Rodin Therapeutics, Inc. Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
CN106939024A (en) * 2016-01-04 2017-07-11 上海和辉光电有限公司 A kind of tetradentate ligandses Pt complex compounds of unit based on miscellaneous nitrogen fluorenes for OLED material
CN107021987A (en) * 2016-01-29 2017-08-08 上海和辉光电有限公司 A kind of tetradentate ligandses Pt complex compounds of unit based on miscellaneous nitrogen fluorenes for OLED material
KR102654858B1 (en) 2016-02-11 2024-04-05 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
US10672997B2 (en) 2016-06-20 2020-06-02 Universal Display Corporation Organic electroluminescent materials and devices
EP3266790B1 (en) 2016-07-05 2019-11-06 Samsung Electronics Co., Ltd Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound
KR102673814B1 (en) * 2016-08-25 2024-06-10 삼성전자주식회사 Organometallic compound and organic light emitting device including the same
KR102673810B1 (en) 2016-09-27 2024-06-10 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
KR102654864B1 (en) 2016-11-18 2024-04-05 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
WO2018132531A1 (en) 2017-01-11 2018-07-19 Rodin Therapeutics, Inc. Bicyclic inhibitors of histone deacetylase
KR102610833B1 (en) * 2017-02-15 2023-12-07 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
US10811621B2 (en) 2017-02-15 2020-10-20 Samsung Electronics Co., Ltd. Organometallic compound, organic light-emitting device including the organometallic compound, and a diagnostic composition including the organometallic compound
KR20180098011A (en) 2017-02-24 2018-09-03 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
KR102390377B1 (en) 2017-03-02 2022-04-25 삼성전자주식회사 Organometallic compound and organic light emitting device including the same
KR20180117919A (en) 2017-04-20 2018-10-30 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
KR102429875B1 (en) 2017-04-21 2022-08-05 삼성전자주식회사 Organometallic compound and organic light emitting device including the same
KR102461719B1 (en) 2017-05-23 2022-11-01 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
KR20180137311A (en) * 2017-06-16 2018-12-27 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
SG11202000970WA (en) 2017-08-07 2020-02-27 Rodin Therapeutics Inc Bicyclic inhibitors of histone deacetylase
US11081693B2 (en) 2017-08-30 2021-08-03 Samsung Electronics Co., Ltd. Composite cathode active material, method of preparing the same, and cathode and lithium battery including the composite cathode active material
US11289668B2 (en) 2017-09-05 2022-03-29 Samsung Electronics Co., Ltd. Organic light-emitting device
KR102486390B1 (en) * 2017-09-07 2023-01-09 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
KR102519181B1 (en) * 2017-09-29 2023-04-06 삼성전자주식회사 Organometallic compound, organic light emitting device including the same and a composition for diagnosing including the same
CN109980111B (en) * 2017-12-28 2021-02-19 广东阿格蕾雅光电材料有限公司 Organic electroluminescent device containing tetradentate platinum (II) complex
HUE057970T2 (en) 2018-03-08 2022-06-28 Incyte Corp Aminopyrazine diol compounds as pi3k-y inhibitors
US11296283B2 (en) 2018-06-04 2022-04-05 Universal Display Corporation Organic electroluminescent materials and devices
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors
US20200176691A1 (en) * 2018-12-04 2020-06-04 The University Of Hong Kong Transition metal luminescent complexes and methods of use
CN111320613B (en) * 2018-12-17 2023-05-12 广东阿格蕾雅光电材料有限公司 Platinum (II) tetradentate ONNO complex luminescent material, preparation method and application thereof in organic light-emitting diode
CN109841759A (en) * 2018-12-29 2019-06-04 香港大学深圳研究院 A kind of OLED device and preparation method thereof based on platinum complex
CN109802047A (en) * 2018-12-29 2019-05-24 香港大学深圳研究院 A kind of organic luminescent device and preparation method thereof based on infrared band
CN112940040B (en) * 2019-12-11 2022-06-10 广东阿格蕾雅光电材料有限公司 Preparation and application of tetradentate platinum (II) complex
CN113698432B (en) * 2020-05-21 2024-03-08 广东阿格蕾雅光电材料有限公司 Preparation and application of tetradentate platinum (II) complex

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442797B2 (en) 2003-11-04 2008-10-28 Takasago International Corporation Platinum complex and light emitting device
US20100140602A1 (en) * 2008-12-09 2010-06-10 Fujifilm Corporation Organic electroluminescence device
US20130009118A1 (en) 2010-03-23 2013-01-10 Philipp Stoessel Materials for organic electroluminescent devices
US20140138632A1 (en) 2012-11-19 2014-05-22 Samsung Display Co., Ltd. Amine-based compound and organic light- emitting device including the same
US8877353B2 (en) * 2010-07-21 2014-11-04 Versitech Limited Platinum (II) tetradentate ONCN complexes for organic light-emitting diode applications

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060134461A1 (en) * 2004-12-17 2006-06-22 Shouquan Huo Organometallic materials and electroluminescent devices
JP4959270B2 (en) 2005-09-30 2012-06-20 富士フイルム株式会社 Organic electroluminescence device

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7442797B2 (en) 2003-11-04 2008-10-28 Takasago International Corporation Platinum complex and light emitting device
US20100140602A1 (en) * 2008-12-09 2010-06-10 Fujifilm Corporation Organic electroluminescence device
US20130009118A1 (en) 2010-03-23 2013-01-10 Philipp Stoessel Materials for organic electroluminescent devices
US8877353B2 (en) * 2010-07-21 2014-11-04 Versitech Limited Platinum (II) tetradentate ONCN complexes for organic light-emitting diode applications
US20140138632A1 (en) 2012-11-19 2014-05-22 Samsung Display Co., Ltd. Amine-based compound and organic light- emitting device including the same

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Office Action dated Jun. 30, 2015 in U.S. Appl. No. 13/861,119.
Restriction Requirement dated Oct. 8, 2014 in U.S. Appl. No. 13/861,119.

Also Published As

Publication number Publication date
US10243154B2 (en) 2019-03-26
KR101749611B1 (en) 2017-06-21
US20160181551A1 (en) 2016-06-23
US20130274473A1 (en) 2013-10-17
KR20140140075A (en) 2014-12-08
CN104245714A (en) 2014-12-24
US20180233680A1 (en) 2018-08-16
DE112013001975T5 (en) 2015-01-15
WO2013152727A1 (en) 2013-10-17
US9306178B2 (en) 2016-04-05
CN104245714B (en) 2017-09-26

Similar Documents

Publication Publication Date Title
US10243154B2 (en) Platinum(II) complexes for OLED applications
US20230083303A1 (en) Polycyclic compound and an organic electroluminescence device comprising the polycyclic compound or the composition
US10316013B2 (en) Organic light emitting compound and organic light emitting device including the same
KR101497124B1 (en) Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR101161290B1 (en) Fused aromatic compound and organic electroluminescent device using the same
US10026901B2 (en) Organic electronic material and organic electroluminescent device
KR101779913B1 (en) Spiro compound and organic electroluminescent devices comprising the same
US8999522B2 (en) 6H-indolo[2,3-b]quinoxaline derivatives and organic light emitting diode using the same
KR101529157B1 (en) Organic light compound and organic light device using the same
KR101559430B1 (en) Organic light compound and organic light device using the same
JP6580613B2 (en) Lighting for plant cultivation using a novel triazine compound
US8642189B2 (en) Substituted bipyridyl compound and organic electroluminescent device
US11827623B2 (en) Heterocyclic compound, organic light emitting diode comprising same, composition for organic layer of organic light emitting diode, and method for manufacturing organic light emitting diode
EP3263555B1 (en) Hetero ring compound and organic luminescent element comprising same
US11476425B2 (en) Heterocyclic compound and organic light emitting element comprising same
JP2023520184A (en) Organic light-emitting device using polycyclic aromatic derivative compound
JP2012167058A (en) 1,8-aryl-substituted naphthalene derivative exhibiting excimer characteristic, and organic el element obtained by using the same
US20170040546A1 (en) Novel compound and organic electronic device using the same
JP2023511161A (en) Polycyclic aromatic derivative compound and organic light-emitting device using the same
JP2023011540A (en) Polycyclic compound and organic electroluminescent device using the same
TWI542586B (en) Compound having substituted bipyridyl and pyridoindole ring structure, and organic electroluminescent device
JP2023518759A (en) Organic light-emitting device using polycyclic aromatic derivative compound
KR102169446B1 (en) An organoelectroluminescent compounds and organoelectroluminescent device using the same
KR101736119B1 (en) Organic metal compound and organic electroluminescent devices comprising the same
JP2023518069A (en) Organic light-emitting device using polycyclic aromatic derivative compound

Legal Events

Date Code Title Description
AS Assignment

Owner name: THE UNIVERSITY OF HONG KONG, CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CHE, CHI MING;KUI, CHI FAI;KWOK, CHI CHUNG;REEL/FRAME:038017/0595

Effective date: 20130801

Owner name: VERSITECH LIMITED, CHINA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:THE UNIVERSITY OF HONG KONG;REEL/FRAME:038017/0705

Effective date: 20150413

STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
MAFP Maintenance fee payment

Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Year of fee payment: 4